The benchtop sequencers market is projected to reach $5.73 billion by 2036, at a CAGR of 9.1% from 2026 to 2036. The growth of this market is primarily fueled by the decentralization of clinical sequencing from reference laboratories to point-of-care institutions, platform competition improving cost, accuracy, and turnaround concurrently, and public-health genomic surveillance and biosecurity funding supporting distributed capacity. Additionally, integrated sample-to-report automation and AI variant interpretation creating recurring software revenue, emerging-market national genome programmes and decentralized public-health networks, and rapid-turnaround, infrastructure-light platform designs expanding the number of addressable sites are expected to create substantial growth opportunities for market participants.
The key players operating in the benchtop sequencers market are Illumina, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Oxford Nanopore Technologies plc (U.K.), Pacific Biosciences of California, Inc. (U.S.), Element Biosciences, Inc. (U.S.), MGI Tech Co., Ltd. (China), QIAGEN N.V. (Netherlands), Agilent Technologies, Inc. (U.S.), BGI Genomics Co., Ltd. (China), Singular Genomics Systems, Inc. (U.S.), Ultima Genomics, Inc. (U.S.), Twist Bioscience Corporation (U.S.), 10x Genomics, Inc. (U.S.), and Bio-Rad Laboratories, Inc. (U.S.).
The benchtop sequencers market study presents historical market data value (2025), estimated current data (2026), and forecasts for 2036. This market is segmented by product, technology, read type, throughput, application, end user, and geography.
Among all the products, the Consumables & Reagents segment is expected to account for the largest share of the benchtop sequencers market in 2026. The dominant position of this segment is primarily attributed to per-run consumption of flow cells, sequencing reagents, and library-preparation kits, and platform lock-in once a clinical assay is validated, given a five- to eight-year instrument life over which cumulative consumable spend typically exceeds the original capital purchase. The Software & Services segment, however, is projected to register the highest CAGR during the forecast period, driven by CAP/CLIA pipeline validation requirements, tightened 2026 compliance expectations, and AI-assisted variant interpretation sold on subscription.
Among all the technologies, Sequencing by Synthesis (SBS) is expected to account for the largest share of the market in 2026, supported by the largest validated assay ecosystem, an extensive published-evidence base, and an installed base whose CAP/CLIA-validated workflows are costly to replace. Nanopore sequencing and newer chemistries, including Roche's Sequencing by Expansion (SBX) launching on Axelios in 2026 and avidity-based approaches such as Element Biosciences' AVITI platform, however, are projected to grow fastest, driven by real-time, long-read, and native-modification capabilities that resolve structural variation and epigenetic marks poorly served by short reads.
Among all the applications, Clinical Diagnostics & Oncology accounts for the largest share of the market in 2026, driven by comprehensive genomic profiling for therapy selection and rare-disease diagnosis backed by established reimbursement and clinical-guideline support. Infectious Disease & Genomic Surveillance, however, is projected to grow fastest, supported by public-health funding such as the proposed $52 million FY 2026 CDC Biothreat Radar allocation and by reported returns of approximately $31 per $1 invested in the GenomeTrakr foodborne surveillance network.
Among all the end users, Hospitals & Clinical Laboratories account for the largest share of the market in 2026, reflecting in-house molecular pathology capability and existing CAP/CLIA accreditation. Public Health & Government Laboratories, meanwhile, are projected to register the fastest growth, driven by biosurveillance mandates and multi-year framework procurement.
Among all the geographies, North America accounts for the largest share of the benchtop sequencers market in 2026, reflecting the density of CAP/CLIA-accredited laboratories, established reimbursement for comprehensive genomic profiling, and federal biosurveillance funding. Asia-Pacific, however, is expected to register the fastest CAGR during the forecast period, driven by national genome and precision-medicine programmes in China, Japan, South Korea, India, and Singapore, and domestic platform manufacturing that lowers landed instrument cost.
The key players operating in the benchtop sequencers market are Illumina, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Oxford Nanopore Technologies plc (U.K.), Pacific Biosciences of California, Inc. (U.S.), Element Biosciences, Inc. (U.S.), MGI Tech Co., Ltd. (China), QIAGEN N.V. (Netherlands), Agilent Technologies, Inc. (U.S.), BGI Genomics Co., Ltd. (China), Singular Genomics Systems, Inc. (U.S.), Ultima Genomics, Inc. (U.S.), Twist Bioscience Corporation (U.S.), 10x Genomics, Inc. (U.S.), and Bio-Rad Laboratories, Inc. (U.S.).
The benchtop sequencers market study presents historical market data value (2025), estimated current data (2026), and forecasts for 2036. This market is segmented by product, technology, read type, throughput, application, end user, and geography.
Among all the products, the Consumables & Reagents segment is expected to account for the largest share of the benchtop sequencers market in 2026. The dominant position of this segment is primarily attributed to per-run consumption of flow cells, sequencing reagents, and library-preparation kits, and platform lock-in once a clinical assay is validated, given a five- to eight-year instrument life over which cumulative consumable spend typically exceeds the original capital purchase. The Software & Services segment, however, is projected to register the highest CAGR during the forecast period, driven by CAP/CLIA pipeline validation requirements, tightened 2026 compliance expectations, and AI-assisted variant interpretation sold on subscription.
Among all the technologies, Sequencing by Synthesis (SBS) is expected to account for the largest share of the market in 2026, supported by the largest validated assay ecosystem, an extensive published-evidence base, and an installed base whose CAP/CLIA-validated workflows are costly to replace. Nanopore sequencing and newer chemistries, including Roche's Sequencing by Expansion (SBX) launching on Axelios in 2026 and avidity-based approaches such as Element Biosciences' AVITI platform, however, are projected to grow fastest, driven by real-time, long-read, and native-modification capabilities that resolve structural variation and epigenetic marks poorly served by short reads.
Among all the applications, Clinical Diagnostics & Oncology accounts for the largest share of the market in 2026, driven by comprehensive genomic profiling for therapy selection and rare-disease diagnosis backed by established reimbursement and clinical-guideline support. Infectious Disease & Genomic Surveillance, however, is projected to grow fastest, supported by public-health funding such as the proposed $52 million FY 2026 CDC Biothreat Radar allocation and by reported returns of approximately $31 per $1 invested in the GenomeTrakr foodborne surveillance network.
Among all the end users, Hospitals & Clinical Laboratories account for the largest share of the market in 2026, reflecting in-house molecular pathology capability and existing CAP/CLIA accreditation. Public Health & Government Laboratories, meanwhile, are projected to register the fastest growth, driven by biosurveillance mandates and multi-year framework procurement.
Among all the geographies, North America accounts for the largest share of the benchtop sequencers market in 2026, reflecting the density of CAP/CLIA-accredited laboratories, established reimbursement for comprehensive genomic profiling, and federal biosurveillance funding. Asia-Pacific, however, is expected to register the fastest CAGR during the forecast period, driven by national genome and precision-medicine programmes in China, Japan, South Korea, India, and Singapore, and domestic platform manufacturing that lowers landed instrument cost.
Key Questions Answered in the Report:
- What is the current revenue generated by the benchtop sequencers market globally?
- At what rate is the benchtop sequencers market demand projected to grow for the next 10 years?
- What are the historical market sizes and growth rates of the benchtop sequencers market?
- What are the major factors impacting the growth of this market at the regional and country levels? What are the major opportunities for existing players and new entrants in the market?
- Which segments in terms of product, technology, read type, throughput, application, and end user are expected to create major traction for the manufacturers in this market?
- What are the key geographical trends in this market? Which regions/countries are expected to offer significant growth opportunities for the manufacturers operating in the benchtop sequencers market?
- Who are the major players in the benchtop sequencers market? What are their specific product offerings in this market?
- What are the recent strategic developments in the benchtop sequencers market? What are the impacts of these strategic developments on the market?
Table of Contents
1. Introduction
1.1. Market Definition
1.2. Market Scope
1.2.1. Inclusion and Exclusion Criteria
1.2.2. Platforms Included and Excluded, by Vendor
1.3. Market Ecosystem
1.4. Currency and Limitations
1.4.1. Currency
1.4.2. Limitations
1.5. Key Stakeholders
1.2. Market Scope
1.2.1. Inclusion and Exclusion Criteria
1.2.2. Platforms Included and Excluded, by Vendor
1.3. Market Ecosystem
1.4. Currency and Limitations
1.4.1. Currency
1.4.2. Limitations
1.5. Key Stakeholders
2. Research Methodology
2.1. Research Approach
2.2. Data Collection and Validation
2.2.1. Secondary Research
2.2.2. Primary Research and Validation
2.3. Market Assessment
2.3.1. Market Size Estimation
2.3.2. Bottom-Up Approach
2.3.3. Top-Down Approach
2.3.4. Growth Forecast
2.4. Data Triangulation
2.5. Assumptions for the Study
2.2. Data Collection and Validation
2.2.1. Secondary Research
2.2.2. Primary Research and Validation
2.3. Market Assessment
2.3.1. Market Size Estimation
2.3.2. Bottom-Up Approach
2.3.3. Top-Down Approach
2.3.4. Growth Forecast
2.4. Data Triangulation
2.5. Assumptions for the Study
4. Market Insights
4.1. Overview
4.2. Factors Affecting Market Growth
4.2.1. Drivers
4.2.1.1. Decentralisation of Clinical Sequencing from Reference Laboratories to Point-of-Care Institutions
4.2.1.2. Platform Competition Improving Cost, Accuracy, and Turnaround Concurrently
4.2.1.3. Public-Health Genomic Surveillance and Biosecurity Funding Supporting Distributed Sequencing Capacity
4.2.2. Restraints
4.2.2.1. Total Cost of Ownership and Bioinformatics Talent Scarcity Limiting Adoption
4.2.2.2. Consumable Lock-In and Revalidation Cost Constraining Platform Switching
4.2.3. Opportunities
4.2.3.1. Emerging-Market National Genome Programmes and Decentralised Public-Health Networks
4.2.3.2. Integrated Sample-to-Report Automation and AI Variant Interpretation
4.2.4. Challenges
4.2.4.1. Regulatory Validation Burden, Reimbursement Uncertainty, and Genomic Data Governance
4.3. Key Trends
4.3.1. Convergence of Long-Read, Short-Read, and Multiomic Capability on a Single Bench Footprint
4.3.2. Rapid Turnaround, Room-Temperature Reagents, and Infrastructure-Light Deployment as Buying Criteria
4.3.3. Upward Extension of the Benchtop Class into High-Throughput Price Tiers
4.4. Vendor Selection Criteria and Factors Influencing Purchase Decisions
4.5. Use Cases
4.6. Porter's Five Forces Analysis
4.6.1. Bargaining Power of Buyers: Moderate
4.6.2. Bargaining Power of Suppliers: High
4.6.3. Threat of Substitutes: Moderate
4.6.4. Threat of New Entrants: Moderate to High
4.6.5. Degree of Competition: High
4.7. Value Chain Analysis
4.8. Pricing Analysis
4.8.1. Instrument Capital Cost
4.8.2. Cost per Gigabase
4.8.3. Cost per Sample and Total Cost of Ownership
4.9. Technology Analysis
4.9.1. Comparative Platform Assessment
4.9.2. Adjacent Production-Scale Platforms and Their Influence on Benchtop Demand
4.10. Regulatory Landscape
4.11. Reimbursement Landscape for Sequencing-Based Testing
4.12. Genomic Data Governance, Privacy, and Sovereignty Analysis
4.13. Trade, Export Control, and Supply Chain Analysis
4.14. PESTEL Analysis
4.2. Factors Affecting Market Growth
4.2.1. Drivers
4.2.1.1. Decentralisation of Clinical Sequencing from Reference Laboratories to Point-of-Care Institutions
4.2.1.2. Platform Competition Improving Cost, Accuracy, and Turnaround Concurrently
4.2.1.3. Public-Health Genomic Surveillance and Biosecurity Funding Supporting Distributed Sequencing Capacity
4.2.2. Restraints
4.2.2.1. Total Cost of Ownership and Bioinformatics Talent Scarcity Limiting Adoption
4.2.2.2. Consumable Lock-In and Revalidation Cost Constraining Platform Switching
4.2.3. Opportunities
4.2.3.1. Emerging-Market National Genome Programmes and Decentralised Public-Health Networks
4.2.3.2. Integrated Sample-to-Report Automation and AI Variant Interpretation
4.2.4. Challenges
4.2.4.1. Regulatory Validation Burden, Reimbursement Uncertainty, and Genomic Data Governance
4.3. Key Trends
4.3.1. Convergence of Long-Read, Short-Read, and Multiomic Capability on a Single Bench Footprint
4.3.2. Rapid Turnaround, Room-Temperature Reagents, and Infrastructure-Light Deployment as Buying Criteria
4.3.3. Upward Extension of the Benchtop Class into High-Throughput Price Tiers
4.4. Vendor Selection Criteria and Factors Influencing Purchase Decisions
4.5. Use Cases
4.6. Porter's Five Forces Analysis
4.6.1. Bargaining Power of Buyers: Moderate
4.6.2. Bargaining Power of Suppliers: High
4.6.3. Threat of Substitutes: Moderate
4.6.4. Threat of New Entrants: Moderate to High
4.6.5. Degree of Competition: High
4.7. Value Chain Analysis
4.8. Pricing Analysis
4.8.1. Instrument Capital Cost
4.8.2. Cost per Gigabase
4.8.3. Cost per Sample and Total Cost of Ownership
4.9. Technology Analysis
4.9.1. Comparative Platform Assessment
4.9.2. Adjacent Production-Scale Platforms and Their Influence on Benchtop Demand
4.10. Regulatory Landscape
4.11. Reimbursement Landscape for Sequencing-Based Testing
4.12. Genomic Data Governance, Privacy, and Sovereignty Analysis
4.13. Trade, Export Control, and Supply Chain Analysis
4.14. PESTEL Analysis
5. Benchtop Sequencers Market, by Product
5.1. Introduction
5.2. Instruments
5.3. Consumables & Reagents
5.3.1. Flow Cells & Chips
5.3.2. Sequencing Reagents
5.3.3. Library Preparation Kits
5.4. Software & Services
5.4.1. Bioinformatics & Analysis Software
5.4.2. Instrument Service & Support
5.2. Instruments
5.3. Consumables & Reagents
5.3.1. Flow Cells & Chips
5.3.2. Sequencing Reagents
5.3.3. Library Preparation Kits
5.4. Software & Services
5.4.1. Bioinformatics & Analysis Software
5.4.2. Instrument Service & Support
6. Benchtop Sequencers Market, by Technology
6.1. Introduction
6.2. Sequencing by Synthesis (SBS)
6.3. Ion Semiconductor Sequencing
6.4. Nanopore Sequencing
6.5. Avidity Sequencing
6.6. Single-Molecule Real-Time (SMRT) Sequencing
6.7. Other Technologies
6.2. Sequencing by Synthesis (SBS)
6.3. Ion Semiconductor Sequencing
6.4. Nanopore Sequencing
6.5. Avidity Sequencing
6.6. Single-Molecule Real-Time (SMRT) Sequencing
6.7. Other Technologies
7. Benchtop Sequencers Market, by Read Type
7.1. Introduction
7.2. Short-Read Sequencing
7.3. Long-Read Sequencing
7.2. Short-Read Sequencing
7.3. Long-Read Sequencing
8. Benchtop Sequencers Market, by Throughput
8.1. Introduction
8.2. Low Throughput (< 10 GB per Run)
8.3. Mid Throughput (10-100 GB per Run)
8.4. High Throughput (>100 GB per Run)
8.2. Low Throughput (< 10 GB per Run)
8.3. Mid Throughput (10-100 GB per Run)
8.4. High Throughput (>100 GB per Run)
9. Benchtop Sequencers Market, by Application
9.1. Introduction
9.2. Clinical Diagnostics & Oncology
9.2.1. Comprehensive Genomic Profiling
9.2.2. Minimal Residual Disease & Liquid Biopsy
9.2.3. Hereditary & Rare Disease Testing
9.3. Infectious Disease & Genomic Surveillance
9.4. Reproductive & Genetic Health
9.5. Drug Discovery & Translational Research
9.6. Agrigenomics & Applied Testing
9.7. Other Applications
9.2. Clinical Diagnostics & Oncology
9.2.1. Comprehensive Genomic Profiling
9.2.2. Minimal Residual Disease & Liquid Biopsy
9.2.3. Hereditary & Rare Disease Testing
9.3. Infectious Disease & Genomic Surveillance
9.4. Reproductive & Genetic Health
9.5. Drug Discovery & Translational Research
9.6. Agrigenomics & Applied Testing
9.7. Other Applications
10. Benchtop Sequencers Market, by End User
10.1. Introduction
10.2. Hospitals & Clinical Laboratories
10.3. Academic & Research Institutions
10.4. Pharmaceutical & Biotechnology Companies
10.5. Public Health & Government Laboratories
10.6. CROs & Contract Testing Organizations
10.7. Other End Users
10.2. Hospitals & Clinical Laboratories
10.3. Academic & Research Institutions
10.4. Pharmaceutical & Biotechnology Companies
10.5. Public Health & Government Laboratories
10.6. CROs & Contract Testing Organizations
10.7. Other End Users
11. Benchtop Sequencers Market, by Geography
11.1. Introduction
11.2. North America
11.2.1. U.S.
11.2.2. Canada
11.3. Europe
11.3.1. Germany
11.3.2. U.K.
11.3.3. France
11.3.4. Italy
11.3.5. Spain
11.3.6. Switzerland
11.3.7. Netherlands
11.3.8. Nordic Countries
11.3.9. Rest of Europe
11.4. Asia-Pacific
11.4.1. China
11.4.2. Japan
11.4.3. India
11.4.4. South Korea
11.4.5. Singapore
11.4.6. Australia & New Zealand
11.4.7. Rest of Asia-Pacific
11.5. Latin America
11.5.1. Brazil
11.5.2. Mexico
11.5.3. Rest of Latin America
11.6. Middle East & Africa
11.6.1. Saudi Arabia
11.6.2. U.A.E.
11.6.3. Israel
11.6.4. South Africa
11.6.5. Rest of Middle East & Africa
11.2. North America
11.2.1. U.S.
11.2.2. Canada
11.3. Europe
11.3.1. Germany
11.3.2. U.K.
11.3.3. France
11.3.4. Italy
11.3.5. Spain
11.3.6. Switzerland
11.3.7. Netherlands
11.3.8. Nordic Countries
11.3.9. Rest of Europe
11.4. Asia-Pacific
11.4.1. China
11.4.2. Japan
11.4.3. India
11.4.4. South Korea
11.4.5. Singapore
11.4.6. Australia & New Zealand
11.4.7. Rest of Asia-Pacific
11.5. Latin America
11.5.1. Brazil
11.5.2. Mexico
11.5.3. Rest of Latin America
11.6. Middle East & Africa
11.6.1. Saudi Arabia
11.6.2. U.A.E.
11.6.3. Israel
11.6.4. South Africa
11.6.5. Rest of Middle East & Africa
12. Competitive Landscape
12.1. Overview
12.2. Key Growth Strategies
12.3. Competitive Benchmarking
12.4. Competitive Dashboard
12.4.1. Industry Leaders
12.4.2. Market Differentiators
12.4.3. Vanguards
12.4.4. Emerging Companies
12.5. Market Share Analysis (2025)
12.2. Key Growth Strategies
12.3. Competitive Benchmarking
12.4. Competitive Dashboard
12.4.1. Industry Leaders
12.4.2. Market Differentiators
12.4.3. Vanguards
12.4.4. Emerging Companies
12.5. Market Share Analysis (2025)
13. Company Profiles
13.1. Illumina, Inc.
13.1.1. Business Overview
13.1.2. Financial Overview
13.1.3. Benchtop Sequencers Portfolio
13.1.4. Strategic Developments
13.1.5. SWOT Analysis
13.2. Thermo Fisher Scientific Inc.
13.2.1. Business Overview
13.2.2. Financial Overview
13.2.3. Benchtop Sequencers Portfolio
13.2.4. Strategic Developments
13.2.5. SWOT Analysis
13.3. Oxford Nanopore Technologies plc
13.3.1. Business Overview
13.3.2. Financial Overview
13.3.3. Benchtop Sequencers Portfolio
13.3.4. Strategic Developments
13.3.5. SWOT Analysis
13.4. Pacific Biosciences of California, Inc.
13.4.1. Business Overview
13.4.2. Financial Overview
13.4.3. Benchtop Sequencers Portfolio
13.4.4. Strategic Developments
13.4.5. SWOT Analysis
13.5. Element Biosciences, Inc.
13.5.1. Business Overview
13.5.2. Financial Overview
13.5.3. Benchtop Sequencers Portfolio
13.5.4. Strategic Developments
13.5.5. SWOT Analysis
13.6. MGI Tech Co., Ltd.
13.6.1. Business Overview
13.6.2. Financial Overview
13.6.3. Benchtop Sequencers Portfolio
13.6.4. Strategic Developments
13.6.5. SWOT Analysis
13.7. Complete Genomics, Inc.
13.7.1. Business Overview
13.7.2. Benchtop Sequencers Portfolio
13.7.3. Strategic Developments
13.7.4. SWOT Analysis
13.8. Singular Genomics Systems, Inc.
13.8.1. Business Overview
13.8.2. Benchtop Sequencers Portfolio
13.8.3. Strategic Developments
13.8.4. SWOT Analysis
13.9. GeneMind Biosciences Co., Ltd.
13.9.1. Business Overview
13.9.2. Benchtop Sequencers Portfolio
13.9.3. Strategic Developments
13.9.4. SWOT Analysis
13.10. Salus BioMed
13.10.1. Business Overview
13.10.2. Benchtop Sequencers Portfolio
13.10.3. Strategic Developments
13.10.4. SWOT Analysis
13.11. Qitan Technology Co., Ltd.
13.11.1. Business Overview
13.11.2. Benchtop Sequencers Portfolio
13.11.3. Strategic Developments
13.11.4. SWOT Analysis
13.1.1. Business Overview
13.1.2. Financial Overview
13.1.3. Benchtop Sequencers Portfolio
13.1.4. Strategic Developments
13.1.5. SWOT Analysis
13.2. Thermo Fisher Scientific Inc.
13.2.1. Business Overview
13.2.2. Financial Overview
13.2.3. Benchtop Sequencers Portfolio
13.2.4. Strategic Developments
13.2.5. SWOT Analysis
13.3. Oxford Nanopore Technologies plc
13.3.1. Business Overview
13.3.2. Financial Overview
13.3.3. Benchtop Sequencers Portfolio
13.3.4. Strategic Developments
13.3.5. SWOT Analysis
13.4. Pacific Biosciences of California, Inc.
13.4.1. Business Overview
13.4.2. Financial Overview
13.4.3. Benchtop Sequencers Portfolio
13.4.4. Strategic Developments
13.4.5. SWOT Analysis
13.5. Element Biosciences, Inc.
13.5.1. Business Overview
13.5.2. Financial Overview
13.5.3. Benchtop Sequencers Portfolio
13.5.4. Strategic Developments
13.5.5. SWOT Analysis
13.6. MGI Tech Co., Ltd.
13.6.1. Business Overview
13.6.2. Financial Overview
13.6.3. Benchtop Sequencers Portfolio
13.6.4. Strategic Developments
13.6.5. SWOT Analysis
13.7. Complete Genomics, Inc.
13.7.1. Business Overview
13.7.2. Benchtop Sequencers Portfolio
13.7.3. Strategic Developments
13.7.4. SWOT Analysis
13.8. Singular Genomics Systems, Inc.
13.8.1. Business Overview
13.8.2. Benchtop Sequencers Portfolio
13.8.3. Strategic Developments
13.8.4. SWOT Analysis
13.9. GeneMind Biosciences Co., Ltd.
13.9.1. Business Overview
13.9.2. Benchtop Sequencers Portfolio
13.9.3. Strategic Developments
13.9.4. SWOT Analysis
13.10. Salus BioMed
13.10.1. Business Overview
13.10.2. Benchtop Sequencers Portfolio
13.10.3. Strategic Developments
13.10.4. SWOT Analysis
13.11. Qitan Technology Co., Ltd.
13.11.1. Business Overview
13.11.2. Benchtop Sequencers Portfolio
13.11.3. Strategic Developments
13.11.4. SWOT Analysis
14. Appendix
14.1. Available Customization
14.2. Related Reports
14.2. Related Reports
List of Tables
Table 1. Platform Inclusion and Exclusion Assessment, by Vendor (2026)
Table 2. Indicative Benchtop Sequencer Capital Cost, by Platform Tier (2026)
Table 3. Comparative Assessment of Benchtop Sequencing Technologies (2026)
Table 4. Global Benchtop Sequencers Market, by Product, 2024-2036 (USD Million)
Table 5. Global Benchtop Sequencer Instruments Market, by Country/Region, 2024-2036 (USD Million)
Table 6. Global Benchtop Sequencing Consumables & Reagents Market, by Type, 2024-2036 (USD Million)
Table 7. Global Benchtop Sequencing Consumables & Reagents Market, by Country/Region, 2024-2036 (USD Million)
Table 8. Global Benchtop Sequencing Flow Cells & Chips Market, by Country/Region, 2024-2036 (USD Million)
Table 9. Global Benchtop Sequencing Reagents Market, by Country/Region, 2024-2036 (USD Million)
Table 10. Global Benchtop Sequencing Library Preparation Kits Market, by Country/Region, 2024-2036 (USD Million)
Table 11. Global Benchtop Sequencing Software & Services Market, by Type, 2024-2036 (USD Million)
Table 12. Global Benchtop Sequencing Software & Services Market, by Country/Region, 2024-2036 (USD Million)
Table 13. Global Benchtop Sequencing Bioinformatics & Analysis Software Market, by Country/Region, 2024-2036 (USD Million)
Table 14. Global Benchtop Sequencer Service & Support Market, by Country/Region, 2024-2036 (USD Million)
Table 15. Global Benchtop Sequencers Market, by Technology, 2024-2036 (USD Million)
Table 16. Global Benchtop Sequencers Market for Sequencing by Synthesis (SBS), by Country/Region, 2024-2036 (USD Million)
Table 17. Global Benchtop Sequencers Market for Ion Semiconductor Sequencing, by Country/Region, 2024-2036 (USD Million)
Table 18. Global Benchtop Sequencers Market for Nanopore Sequencing, by Country/Region, 2024-2036 (USD Million)
Table 19. Global Benchtop Sequencers Market for Avidity Sequencing, by Country/Region, 2024-2036 (USD Million)
Table 20. Global Benchtop Sequencers Market for Single-Molecule Real-Time (SMRT) Sequencing, by Country/Region, 2024-2036 (USD Million)
Table 21. Global Benchtop Sequencers Market for Other Technologies, by Country/Region, 2024-2036 (USD Million)
Table 22. Global Benchtop Sequencers Market, by Read Type, 2024-2036 (USD Million)
Table 23. Global Benchtop Sequencers Market for Short-read Sequencing, by Country/Region, 2024-2036 (USD Million)
Table 24. Global Benchtop Sequencers Market for Long-read Sequencing, by Country/Region, 2024-2036 (USD Million)
Table 25. Global Benchtop Sequencers Market, by Throughput, 2024-2036 (USD Million)
Table 26. Global Benchtop Sequencers Market for Low Throughput Sequencing, by Country/Region, 2024-2036 (USD Million)
Table 27. Global Benchtop Sequencers Market for Mid Throughput Sequencing, by Country/Region, 2024-2036 (USD Million)
Table 28. Global Benchtop Sequencers Market for High Throughput Sequencing, by Country/Region, 2024-2036 (USD Million)
Table 29. Global Benchtop Sequencers Market, by Application, 2024-2036 (USD Million)
Table 30. Global Benchtop Sequencers Market for Clinical Diagnostics & Oncology, by Type, 2024-2036 (USD Million)
Table 31. Global Benchtop Sequencers Market for Clinical Diagnostics & Oncology, by Country/Region, 2024-2036 (USD Million)
Table 32. Global Benchtop Sequencers Market for Comprehensive Genomic Profiling, by Country/Region, 2024-2036 (USD Million)
Table 33. Global Benchtop Sequencers Market for Minimal Residual Disease & Liquid Biopsy, by Country/Region, 2024-2036 (USD Million)
Table 34. Global Benchtop Sequencers Market for Hereditary & Rare Disease Testing, by Country/Region, 2024-2036 (USD Million)
Table 35. Global Benchtop Sequencers Market for Infectious Disease & Genomic Surveillance, by Country/Region, 2024-2036 (USD Million)
Table 36. Global Benchtop Sequencers Market for Reproductive & Genetic Health, by Country/Region, 2024-2036 (USD Million)
Table 37. Global Benchtop Sequencers Market for Drug Discovery & Translational Research, by Country/Region, 2024-2036 (USD Million)
Table 38. Global Benchtop Sequencers Market for Agrigenomics & Applied Testing, by Country/Region, 2024-2036 (USD Million)
Table 39. Global Benchtop Sequencers Market for Other Applications, by Country/Region, 2024-2036 (USD Million)
Table 40. Global Benchtop Sequencers Market, by End User, 2024-2036 (USD Million)
Table 41. Global Benchtop Sequencers Market for Hospitals & Clinical Laboratories, by Country/Region, 2024-2036 (USD Million)
Table 42. Global Benchtop Sequencers Market for Academic & Research Institutions, by Country/Region, 2024-2036 (USD Million)
Table 43. Global Benchtop Sequencers Market for Pharmaceutical & Biotechnology Companies, by Country/Region, 2024-2036 (USD Million)
Table 44. Global Benchtop Sequencers Market for Public Health & Government Laboratories, by Country/Region, 2024-2036 (USD Million)
Table 45. Global Benchtop Sequencers Market for CROs & Contract Testing Organizations, by Country/Region, 2024-2036 (USD Million)
Table 46. Global Benchtop Sequencers Market for Other End Users, by Country/Region, 2024-2036 (USD Million)
Table 47. Global Benchtop Sequencers Market, by Region, 2024-2036 (USD Million)
Table 48. Global Benchtop Sequencers Market, by Country/Region, 2024-2036 (USD Million)
Table 49. North America: Benchtop Sequencers Market, by Country/Region, 2024-2036 (USD Million)
Table 50. North America: Benchtop Sequencers Market, by Product, 2024-2036 (USD Million)
Table 51. North America: Benchtop Sequencing Consumables & Reagents Market, by Type, 2024-2036 (USD Million)
Table 52. North America: Benchtop Sequencing Software & Services Market, by Type, 2024-2036 (USD Million)
Table 53. North America: Benchtop Sequencers Market, by Technology, 2024-2036 (USD Million)
Table 54. North America: Benchtop Sequencers Market, by Read Type, 2024-2036 (USD Million)
Table 55. North America: Benchtop Sequencers Market, by Throughput, 2024-2036 (USD Million)
Table 56. North America: Benchtop Sequencers Market, by Application, 2024-2036 (USD Million)
Table 57. North America: Benchtop Sequencers Clinical Diagnostics & Oncology Market, by Type, 2024-2036 (USD Million)
Table 58. North America: Benchtop Sequencers Market, by End User, 2024-2036 (USD Million)
Table 59. U.S.: Benchtop Sequencers Market, by Product, 2024-2036 (USD Million)
Table 60. U.S.: Benchtop Sequencing Consumables & Reagents Market, by Type, 2024-2036 (USD Million)
Table 61. U.S.: Benchtop Sequencing Software & Services Market, by Type, 2024-2036 (USD Million)
Table 62. U.S.: Benchtop Sequencers Market, by Technology, 2024-2036 (USD Million)
Table 63. U.S.: Benchtop Sequencers Market, by Read Type, 2024-2036 (USD Million)
Table 64. U.S.: Benchtop Sequencers Market, by Throughput, 2024-2036 (USD Million)
Table 65. U.S.: Benchtop Sequencers Market, by Application, 2024-2036 (USD Million)
Table 66. U.S.: Benchtop Sequencers Clinical Diagnostics & Oncology Market, by Type, 2024-2036 (USD Million)
Table 67. U.S.: Benchtop Sequencers Market, by End User, 2024-2036 (USD Million)
Table 68. Canada: Benchtop Sequencers Market, by Product, 2024-2036 (USD Million)
Table 69. Canada: Benchtop Sequencing Consumables & Reagents Market, by Type, 2024-2036 (USD Million)
Table 70. Canada: Benchtop Sequencing Software & Services Market, by Type, 2024-2036 (USD Million)
Table 71. Canada: Benchtop Sequencers Market, by Technology, 2024-2036 (USD Million)
Table 72. Canada: Benchtop Sequencers Market, by Read Type, 2024-2036 (USD Million)
Table 73. Canada: Benchtop Sequencers Market, by Throughput, 2024-2036 (USD Million)
Table 74. Canada: Benchtop Sequencers Market, by Application, 2024-2036 (USD Million)
Table 75. Canada: Benchtop Sequencers Clinical Diagnostics & Oncology Market, by Type, 2024-2036 (USD Million)
Table 76. Canada: Benchtop Sequencers Market, by End User, 2024-2036 (USD Million)
Table 77. Europe: Benchtop Sequencers Market, by Country/Region, 2024-2036 (USD Million)
Table 78. Europe: Benchtop Sequencers Market, by Product, 2024-2036 (USD Million)
Table 79. Europe: Benchtop Sequencing Consumables & Reagents Market, by Type, 2024-2036 (USD Million)
Table 80. Europe: Benchtop Sequencing Software & Services Market, by Type, 2024-2036 (USD Million)
Table 81. Europe: Benchtop Sequencers Market, by Technology, 2024-2036 (USD Million)
Table 82. Europe: Benchtop Sequencers Market, by Read Type, 2024-2036 (USD Million)
Table 83. Europe: Benchtop Sequencers Market, by Throughput, 2024-2036 (USD Million)
Table 84. Europe: Benchtop Sequencers Market, by Application, 2024-2036 (USD Million)
Table 85. Europe: Benchtop Sequencers Clinical Diagnostics & Oncology Market, by Type, 2024-2036 (USD Million)
Table 86. Europe: Benchtop Sequencers Market, by End User, 2024-2036 (USD Million)
Table 87. Germany: Benchtop Sequencers Market, by Product, 2024-2036 (USD Million)
Table 88. Germany: Benchtop Sequencing Consumables & Reagents Market, by Type, 2024-2036 (USD Million)
Table 89. Germany: Benchtop Sequencing Software & Services Market, by Type, 2024-2036 (USD Million)
Table 90. Germany: Benchtop Sequencers Market, by Technology, 2024-2036 (USD Million)
Table 91. Germany: Benchtop Sequencers Market, by Read Type, 2024-2036 (USD Million)
Table 92. Germany: Benchtop Sequencers Market, by Throughput, 2024-2036 (USD Million)
Table 93. Germany: Benchtop Sequencers Market, by Application, 2024-2036 (USD Million)
Table 94. Germany: Benchtop Sequencers Clinical Diagnostics & Oncology Market, by Type, 2024-2036 (USD Million)
Table 95. Germany: Benchtop Sequencers Market, by End User, 2024-2036 (USD Million)
Table 96. U.K.: Benchtop Sequencers Market, by Product, 2024-2036 (USD Million)
Table 97. U.K.: Benchtop Sequencing Consumables & Reagents Market, by Type, 2024-2036 (USD Million)
Table 98. U.K.: Benchtop Sequencing Software & Services Market, by Type, 2024-2036 (USD Million)
Table 99. U.K.: Benchtop Sequencers Market, by Technology, 2024-2036 (USD Million)
Table 100. U.K.: Benchtop Sequencers Market, by Read Type, 2024-2036 (USD Million)
Table 101. U.K.: Benchtop Sequencers Market, by Throughput, 2024-2036 (USD Million)
Table 102. U.K.: Benchtop Sequencers Market, by Application, 2024-2036 (USD Million)
Table 103. U.K.: Benchtop Sequencers Clinical Diagnostics & Oncology Market, by Type, 2024-2036 (USD Million)
Table 104. U.K.: Benchtop Sequencers Market, by End User, 2024-2036 (USD Million)
Table 105. France: Benchtop Sequencers Market, by Product, 2024-2036 (USD Million)
Table 106. France: Benchtop Sequencing Consumables & Reagents Market, by Type, 2024-2036 (USD Million)
Table 107. France: Benchtop Sequencing Software & Services Market, by Type, 2024-2036 (USD Million)
Table 108. France: Benchtop Sequencers Market, by Technology, 2024-2036 (USD Million)
Table 109. France: Benchtop Sequencers Market, by Read Type, 2024-2036 (USD Million)
Table 110. France: Benchtop Sequencers Market, by Throughput, 2024-2036 (USD Million)
Table 111. France: Benchtop Sequencers Market, by Application, 2024-2036 (USD Million)
Table 112. France: Benchtop Sequencers Clinical Diagnostics & Oncology Market, by Type, 2024-2036 (USD Million)
Table 113. France: Benchtop Sequencers Market, by End User, 2024-2036 (USD Million)
Table 114. Italy: Benchtop Sequencers Market, by Product, 2024-2036 (USD Million)
Table 115. Italy: Benchtop Sequencing Consumables & Reagents Market, by Type, 2024-2036 (USD Million)
Table 116. Italy: Benchtop Sequencing Software & Services Market, by Type, 2024-2036 (USD Million)
Table 117. Italy: Benchtop Sequencers Market, by Technology, 2024-2036 (USD Million)
Table 118. Italy: Benchtop Sequencers Market, by Read Type, 2024-2036 (USD Million)
Table 119. Italy: Benchtop Sequencers Market, by Throughput, 2024-2036 (USD Million)
Table 120. Italy: Benchtop Sequencers Market, by Application, 2024-2036 (USD Million)
Table 121. Italy: Benchtop Sequencers Clinical Diagnostics & Oncology Market, by Type, 2024-2036 (USD Million)
Table 122. Italy: Benchtop Sequencers Market, by End User, 2024-2036 (USD Million)
Table 123. Spain: Benchtop Sequencers Market, by Product, 2024-2036 (USD Million)
Table 124. Spain: Benchtop Sequencing Consumables & Reagents Market, by Type, 2024-2036 (USD Million)
Table 125. Spain: Benchtop Sequencing Software & Services Market, by Type, 2024-2036 (USD Million)
Table 126. Spain: Benchtop Sequencers Market, by Technology, 2024-2036 (USD Million)
Table 127. Spain: Benchtop Sequencers Market, by Read Type, 2024-2036 (USD Million)
Table 128. Spain: Benchtop Sequencers Market, by Throughput, 2024-2036 (USD Million)
Table 129. Spain: Benchtop Sequencers Market, by Application, 2024-2036 (USD Million)
Table 130. Spain: Benchtop Sequencers Clinical Diagnostics & Oncology Market, by Type, 2024-2036 (USD Million)
Table 131. Spain: Benchtop Sequencers Market, by End User, 2024-2036 (USD Million)
Table 132. Switzerland: Benchtop Sequencers Market, by Product, 2024-2036 (USD Million)
Table 133. Switzerland: Benchtop Sequencing Consumables & Reagents Market, by Type, 2024-2036 (USD Million)
Table 134. Switzerland: Benchtop Sequencing Software & Services Market, by Type, 2024-2036 (USD Million)
Table 135. Switzerland: Benchtop Sequencers Market, by Technology, 2024-2036 (USD Million)
Table 136. Switzerland: Benchtop Sequencers Market, by Read Type, 2024-2036 (USD Million)
Table 137. Switzerland: Benchtop Sequencers Market, by Throughput, 2024-2036 (USD Million)
Table 138. Switzerland: Benchtop Sequencers Market, by Application, 2024-2036 (USD Million)
Table 139. Switzerland: Benchtop Sequencers Clinical Diagnostics & Oncology Market, by Type, 2024-2036 (USD Million)
Table 140. Switzerland: Benchtop Sequencers Market, by End User, 2024-2036 (USD Million)
Table 141. Netherlands: Benchtop Sequencers Market, by Product, 2024-2036 (USD Million)
Table 142. Netherlands: Benchtop Sequencing Consumables & Reagents Market, by Type, 2024-2036 (USD Million)
Table 143. Netherlands: Benchtop Sequencing Software & Services Market, by Type, 2024-2036 (USD Million)
Table 144. Netherlands: Benchtop Sequencers Market, by Technology, 2024-2036 (USD Million)
Table 145. Netherlands: Benchtop Sequencers Market, by Read Type, 2024-2036 (USD Million)
Table 146. Netherlands: Benchtop Sequencers Market, by Throughput, 2024-2036 (USD Million)
Table 147. Netherlands: Benchtop Sequencers Market, by Application, 2024-2036 (USD Million)
Table 148. Netherlands: Benchtop Sequencers Clinical Diagnostics & Oncology Market, by Type, 2024-2036 (USD Million)
Table 149. Netherlands: Benchtop Sequencers Market, by End User, 2024-2036 (USD Million)
Table 150. Nordic Countries: Benchtop Sequencers Market, by Product, 2024-2036 (USD Million)
Table 151. Nordic Countries: Benchtop Sequencing Consumables & Reagents Market, by Type, 2024-2036 (USD Million)
Table 152. Nordic Countries: Benchtop Sequencing Software & Services Market, by Type, 2024-2036 (USD Million)
Table 153. Nordic Countries: Benchtop Sequencers Market, by Technology, 2024-2036 (USD Million)
Table 154. Nordic Countries: Benchtop Sequencers Market, by Read Type, 2024-2036 (USD Million)
Table 155. Nordic Countries: Benchtop Sequencers Market, by Throughput, 2024-2036 (USD Million)
Table 156. Nordic Countries: Benchtop Sequencers Market, by Application, 2024-2036 (USD Million)
Table 157. Nordic Countries: Benchtop Sequencers Clinical Diagnostics & Oncology Market, by Type, 2024-2036 (USD Million)
Table 158. Nordic Countries: Benchtop Sequencers Market, by End User, 2024-2036 (USD Million)
Table 159. Rest of Europe: Benchtop Sequencers Market, by Product, 2024-2036 (USD Million)
Table 160. Rest of Europe: Benchtop Sequencing Consumables & Reagents Market, by Type, 2024-2036 (USD Million)
Table 161. Rest of Europe: Benchtop Sequencing Software & Services Market, by Type, 2024-2036 (USD Million)
Table 162. Rest of Europe: Benchtop Sequencers Market, by Technology, 2024-2036 (USD Million)
Table 163. Rest of Europe: Benchtop Sequencers Market, by Read Type, 2024-2036 (USD Million)
Table 164. Rest of Europe: Benchtop Sequencers Market, by Throughput, 2024-2036 (USD Million)
Table 165. Rest of Europe: Benchtop Sequencers Market, by Application, 2024-2036 (USD Million)
Table 166. Rest of Europe: Benchtop Sequencers Clinical Diagnostics & Oncology Market, by Type, 2024-2036 (USD Million)
Table 167. Rest of Europe: Benchtop Sequencers Market, by End User, 2024-2036 (USD Million)
Table 168. Asia-Pacific: Benchtop Sequencers Market, by Country/Region, 2024-2036 (USD Million)
Table 169. Asia-Pacific: Benchtop Sequencers Market, by Product, 2024-2036 (USD Million)
Table 170. Asia-Pacific: Benchtop Sequencing Consumables & Reagents Market, by Type, 2024-2036 (USD Million)
Table 171. Asia-Pacific: Benchtop Sequencing Software & Services Market, by Type, 2024-2036 (USD Million)
Table 172. Asia-Pacific: Benchtop Sequencers Market, by Technology, 2024-2036 (USD Million)
Table 173. Asia-Pacific: Benchtop Sequencers Market, by Read Type, 2024-2036 (USD Million)
Table 174. Asia-Pacific: Benchtop Sequencers Market, by Throughput, 2024-2036 (USD Million)
Table 175. Asia-Pacific: Benchtop Sequencers Market, by Application, 2024-2036 (USD Million)
Table 176. Asia-Pacific: Benchtop Sequencers Clinical Diagnostics & Oncology Market, by Type, 2024-2036 (USD Million)
Table 177. Asia-Pacific: Benchtop Sequencers Market, by End User, 2024-2036 (USD Million)
Table 178. China: Benchtop Sequencers Market, by Product, 2024-2036 (USD Million)
Table 179. China: Benchtop Sequencing Consumables & Reagents Market, by Type, 2024-2036 (USD Million)
Table 180. China: Benchtop Sequencing Software & Services Market, by Type, 2024-2036 (USD Million)
Table 181. China: Benchtop Sequencers Market, by Technology, 2024-2036 (USD Million)
Table 182. China: Benchtop Sequencers Market, by Read Type, 2024-2036 (USD Million)
Table 183. China: Benchtop Sequencers Market, by Throughput, 2024-2036 (USD Million)
Table 184. China: Benchtop Sequencers Market, by Application, 2024-2036 (USD Million)
Table 185. China: Benchtop Sequencers Clinical Diagnostics & Oncology Market, by Type, 2024-2036 (USD Million)
Table 186. China: Benchtop Sequencers Market, by End User, 2024-2036 (USD Million)
Table 187. Japan: Benchtop Sequencers Market, by Product, 2024-2036 (USD Million)
Table 188. Japan: Benchtop Sequencing Consumables & Reagents Market, by Type, 2024-2036 (USD Million)
Table 189. Japan: Benchtop Sequencing Software & Services Market, by Type, 2024-2036 (USD Million)
Table 190. Japan: Benchtop Sequencers Market, by Technology, 2024-2036 (USD Million)
Table 191. Japan: Benchtop Sequencers Market, by Read Type, 2024-2036 (USD Million)
Table 192. Japan: Benchtop Sequencers Market, by Throughput, 2024-2036 (USD Million)
Table 193. Japan: Benchtop Sequencers Market, by Application, 2024-2036 (USD Million)
Table 194. Japan: Benchtop Sequencers Clinical Diagnostics & Oncology Market, by Type, 2024-2036 (USD Million)
Table 195. Japan: Benchtop Sequencers Market, by End User, 2024-2036 (USD Million)
Table 196. India: Benchtop Sequencers Market, by Product, 2024-2036 (USD Million)
Table 197. India: Benchtop Sequencing Consumables & Reagents Market, by Type, 2024-2036 (USD Million)
Table 198. India: Benchtop Sequencing Software & Services Market, by Type, 2024-2036 (USD Million)
Table 199. India: Benchtop Sequencers Market, by Technology, 2024-2036 (USD Million)
Table 200. India: Benchtop Sequencers Market, by Read Type, 2024-2036 (USD Million)
Table 201. India: Benchtop Sequencers Market, by Throughput, 2024-2036 (USD Million)
Table 202. India: Benchtop Sequencers Market, by Application, 2024-2036 (USD Million)
Table 203. India: Benchtop Sequencers Clinical Diagnostics & Oncology Market, by Type, 2024-2036 (USD Million)
Table 204. India: Benchtop Sequencers Market, by End User, 2024-2036 (USD Million)
Table 205. South Korea: Benchtop Sequencers Market, by Product, 2024-2036 (USD Million)
Table 206. South Korea: Benchtop Sequencing Consumables & Reagents Market, by Type, 2024-2036 (USD Million)
Table 207. South Korea: Benchtop Sequencing Software & Services Market, by Type, 2024-2036 (USD Million)
Table 208. South Korea: Benchtop Sequencers Market, by Technology, 2024-2036 (USD Million)
Table 209. South Korea: Benchtop Sequencers Market, by Read Type, 2024-2036 (USD Million)
Table 210. South Korea: Benchtop Sequencers Market, by Throughput, 2024-2036 (USD Million)
Table 211. South Korea: Benchtop Sequencers Market, by Application, 2024-2036 (USD Million)
Table 212. South Korea: Benchtop Sequencers Clinical Diagnostics & Oncology Market, by Type, 2024-2036 (USD Million)
Table 213. South Korea: Benchtop Sequencers Market, by End User, 2024-2036 (USD Million)
Table 214. Singapore: Benchtop Sequencers Market, by Product, 2024-2036 (USD Million)
Table 215. Singapore: Benchtop Sequencing Consumables & Reagents Market, by Type, 2024-2036 (USD Million)
Table 216. Singapore: Benchtop Sequencing Software & Services Market, by Type, 2024-2036 (USD Million)
Table 217. Singapore: Benchtop Sequencers Market, by Technology, 2024-2036 (USD Million)
Table 218. Singapore: Benchtop Sequencers Market, by Read Type, 2024-2036 (USD Million)
Table 219. Singapore: Benchtop Sequencers Market, by Throughput, 2024-2036 (USD Million)
Table 220. Singapore: Benchtop Sequencers Market, by Application, 2024-2036 (USD Million)
Table 221. Singapore: Benchtop Sequencers Clinical Diagnostics & Oncology Market, by Type, 2024-2036 (USD Million)
Table 222. Singapore: Benchtop Sequencers Market, by End User, 2024-2036 (USD Million)
Table 223. Australia & New Zealand: Benchtop Sequencers Market, by Product, 2024-2036 (USD Million)
Table 224. Australia & New Zealand: Benchtop Sequencing Consumables & Reagents Market, by Type, 2024-2036 (USD Million)
Table 225. Australia & New Zealand: Benchtop Sequencing Software & Services Market, by Type, 2024-2036 (USD Million)
Table 226. Australia & New Zealand: Benchtop Sequencers Market, by Technology, 2024-2036 (USD Million)
Table 227. Australia & New Zealand: Benchtop Sequencers Market, by Read Type, 2024-2036 (USD Million)
Table 228. Australia & New Zealand: Benchtop Sequencers Market, by Throughput, 2024-2036 (USD Million)
Table 229. Australia & New Zealand: Benchtop Sequencers Market, by Application, 2024-2036 (USD Million)
Table 230. Australia & New Zealand: Benchtop Sequencers Clinical Diagnostics & Oncology Market, by Type, 2024-2036 (USD Million)
Table 231. Australia & New Zealand: Benchtop Sequencers Market, by End User, 2024-2036 (USD Million)
Table 232. Rest of Asia-Pacific: Benchtop Sequencers Market, by Product, 2024-2036 (USD Million)
Table 233. Rest of Asia-Pacific: Benchtop Sequencing Consumables & Reagents Market, by Type, 2024-2036 (USD Million)
Table 234. Rest of Asia-Pacific: Benchtop Sequencing Software & Services Market, by Type, 2024-2036 (USD Million)
Table 235. Rest of Asia-Pacific: Benchtop Sequencers Market, by Technology, 2024-2036 (USD Million)
Table 236. Rest of Asia-Pacific: Benchtop Sequencers Market, by Read Type, 2024-2036 (USD Million)
Table 237. Rest of Asia-Pacific: Benchtop Sequencers Market, by Throughput, 2024-2036 (USD Million)
Table 238. Rest of Asia-Pacific: Benchtop Sequencers Market, by Application, 2024-2036 (USD Million)
Table 239. Rest of Asia-Pacific: Benchtop Sequencers Clinical Diagnostics & Oncology Market, by Type, 2024-2036 (USD Million)
Table 240. Rest of Asia-Pacific: Benchtop Sequencers Market, by End User, 2024-2036 (USD Million)
Table 241. Latin America: Benchtop Sequencers Market, by Country/Region, 2024-2036 (USD Million)
Table 242. Latin America: Benchtop Sequencers Market, by Product, 2024-2036 (USD Million)
Table 243. Latin America: Benchtop Sequencing Consumables & Reagents Market, by Type, 2024-2036 (USD Million)
Table 244. Latin America: Benchtop Sequencing Software & Services Market, by Type, 2024-2036 (USD Million)
Table 245. Latin America: Benchtop Sequencers Market, by Technology, 2024-2036 (USD Million)
Table 246. Latin America: Benchtop Sequencers Market, by Read Type, 2024-2036 (USD Million)
Table 247. Latin America: Benchtop Sequencers Market, by Throughput, 2024-2036 (USD Million)
Table 248. Latin America: Benchtop Sequencers Market, by Application, 2024-2036 (USD Million)
Table 249. Latin America: Benchtop Sequencers Clinical Diagnostics & Oncology Market, by Type, 2024-2036 (USD Million)
Table 250. Latin America: Benchtop Sequencers Market, by End User, 2024-2036 (USD Million)
Table 251. Brazil: Benchtop Sequencers Market, by Product, 2024-2036 (USD Million)
Table 252. Brazil: Benchtop Sequencing Consumables & Reagents Market, by Type, 2024-2036 (USD Million)
Table 253. Brazil: Benchtop Sequencing Software & Services Market, by Type, 2024-2036 (USD Million)
Table 254. Brazil: Benchtop Sequencers Market, by Technology, 2024-2036 (USD Million)
Table 255. Brazil: Benchtop Sequencers Market, by Read Type, 2024-2036 (USD Million)
Table 256. Brazil: Benchtop Sequencers Market, by Throughput, 2024-2036 (USD Million)
Table 257. Brazil: Benchtop Sequencers Market, by Application, 2024-2036 (USD Million)
Table 258. Brazil: Benchtop Sequencers Clinical Diagnostics & Oncology Market, by Type, 2024-2036 (USD Million)
Table 259. Brazil: Benchtop Sequencers Market, by End User, 2024-2036 (USD Million)
Table 260. Mexico: Benchtop Sequencers Market, by Product, 2024-2036 (USD Million)
Table 261. Mexico: Benchtop Sequencing Consumables & Reagents Market, by Type, 2024-2036 (USD Million)
Table 262. Mexico: Benchtop Sequencing Software & Services Market, by Type, 2024-2036 (USD Million)
Table 263. Mexico: Benchtop Sequencers Market, by Technology, 2024-2036 (USD Million)
Table 264. Mexico: Benchtop Sequencers Market, by Read Type, 2024-2036 (USD Million)
Table 265. Mexico: Benchtop Sequencers Market, by Throughput, 2024-2036 (USD Million)
Table 266. Mexico: Benchtop Sequencers Market, by Application, 2024-2036 (USD Million)
Table 267. Mexico: Benchtop Sequencers Clinical Diagnostics & Oncology Market, by Type, 2024-2036 (USD Million)
Table 268. Mexico: Benchtop Sequencers Market, by End User, 2024-2036 (USD Million)
Table 269. Rest of Latin America: Benchtop Sequencers Market, by Product, 2024-2036 (USD Million)
Table 270. Rest of Latin America: Benchtop Sequencing Consumables & Reagents Market, by Type, 2024-2036 (USD Million)
Table 271. Rest of Latin America: Benchtop Sequencing Software & Services Market, by Type, 2024-2036 (USD Million)
Table 272. Rest of Latin America: Benchtop Sequencers Market, by Technology, 2024-2036 (USD Million)
Table 273. Rest of Latin America: Benchtop Sequencers Market, by Read Type, 2024-2036 (USD Million)
Table 274. Rest of Latin America: Benchtop Sequencers Market, by Throughput, 2024-2036 (USD Million)
Table 275. Rest of Latin America: Benchtop Sequencers Market, by Application, 2024-2036 (USD Million)
Table 276. Rest of Latin America: Benchtop Sequencers Clinical Diagnostics & Oncology Market, by Type, 2024-2036 (USD Million)
Table 277. Rest of Latin America: Benchtop Sequencers Market, by End User, 2024-2036 (USD Million)
Table 278. Middle East & Africa: Benchtop Sequencers Market, by Country/Region, 2024-2036 (USD Million)
Table 279. Middle East & Africa: Benchtop Sequencers Market, by Product, 2024-2036 (USD Million)
Table 280. Middle East & Africa: Benchtop Sequencing Consumables & Reagents Market, by Type, 2024-2036 (USD Million)
Table 281. Middle East & Africa: Benchtop Sequencing Software & Services Market, by Type, 2024-2036 (USD Million)
Table 282. Middle East & Africa: Benchtop Sequencers Market, by Technology, 2024-2036 (USD Million)
Table 283. Middle East & Africa: Benchtop Sequencers Market, by Read Type, 2024-2036 (USD Million)
Table 284. Middle East & Africa: Benchtop Sequencers Market, by Throughput, 2024-2036 (USD Million)
Table 285. Middle East & Africa: Benchtop Sequencers Market, by Application, 2024-2036 (USD Million)
Table 286. Middle East & Africa: Benchtop Sequencers Clinical Diagnostics & Oncology Market, by Type, 2024-2036 (USD Million)
Table 287. Middle East & Africa: Benchtop Sequencers Market, by End User, 2024-2036 (USD Million)
Table 288. Saudi Arabia: Benchtop Sequencers Market, by Product, 2024-2036 (USD Million)
Table 289. Saudi Arabia: Benchtop Sequencing Consumables & Reagents Market, by Type, 2024-2036 (USD Million)
Table 290. Saudi Arabia: Benchtop Sequencing Software & Services Market, by Type, 2024-2036 (USD Million)
Table 291. Saudi Arabia: Benchtop Sequencers Market, by Technology, 2024-2036 (USD Million)
Table 292. Saudi Arabia: Benchtop Sequencers Market, by Read Type, 2024-2036 (USD Million)
Table 293. Saudi Arabia: Benchtop Sequencers Market, by Throughput, 2024-2036 (USD Million)
Table 294. Saudi Arabia: Benchtop Sequencers Market, by Application, 2024-2036 (USD Million)
Table 295. Saudi Arabia: Benchtop Sequencers Clinical Diagnostics & Oncology Market, by Type, 2024-2036 (USD Million)
Table 296. Saudi Arabia: Benchtop Sequencers Market, by End User, 2024-2036 (USD Million)
Table 297. U.A.E.: Benchtop Sequencers Market, by Product, 2024-2036 (USD Million)
Table 298. U.A.E.: Benchtop Sequencing Consumables & Reagents Market, by Type, 2024-2036 (USD Million)
Table 299. U.A.E.: Benchtop Sequencing Software & Services Market, by Type, 2024-2036 (USD Million)
Table 300. U.A.E.: Benchtop Sequencers Market, by Technology, 2024-2036 (USD Million)
Table 301. U.A.E.: Benchtop Sequencers Market, by Read Type, 2024-2036 (USD Million)
Table 302. U.A.E.: Benchtop Sequencers Market, by Throughput, 2024-2036 (USD Million)
Table 303. U.A.E.: Benchtop Sequencers Market, by Application, 2024-2036 (USD Million)
Table 304. U.A.E.: Benchtop Sequencers Clinical Diagnostics & Oncology Market, by Type, 2024-2036 (USD Million)
Table 305. U.A.E.: Benchtop Sequencers Market, by End User, 2024-2036 (USD Million)
Table 306. Israel: Benchtop Sequencers Market, by Product, 2024-2036 (USD Million)
Table 307. Israel: Benchtop Sequencing Consumables & Reagents Market, by Type, 2024-2036 (USD Million)
Table 308. Israel: Benchtop Sequencing Software & Services Market, by Type, 2024-2036 (USD Million)
Table 309. Israel: Benchtop Sequencers Market, by Technology, 2024-2036 (USD Million)
Table 310. Israel: Benchtop Sequencers Market, by Read Type, 2024-2036 (USD Million)
Table 311. Israel: Benchtop Sequencers Market, by Throughput, 2024-2036 (USD Million)
Table 312. Israel: Benchtop Sequencers Market, by Application, 2024-2036 (USD Million)
Table 313. Israel: Benchtop Sequencers Clinical Diagnostics & Oncology Market, by Type, 2024-2036 (USD Million)
Table 314. Israel: Benchtop Sequencers Market, by End User, 2024-2036 (USD Million)
Table 315. South Africa: Benchtop Sequencers Market, by Product, 2024-2036 (USD Million)
Table 316. South Africa: Benchtop Sequencing Consumables & Reagents Market, by Type, 2024-2036 (USD Million)
Table 317. South Africa: Benchtop Sequencing Software & Services Market, by Type, 2024-2036 (USD Million)
Table 318. South Africa: Benchtop Sequencers Market, by Technology, 2024-2036 (USD Million)
Table 319. South Africa: Benchtop Sequencers Market, by Read Type, 2024-2036 (USD Million)
Table 320. South Africa: Benchtop Sequencers Market, by Throughput, 2024-2036 (USD Million)
Table 321. South Africa: Benchtop Sequencers Market, by Application, 2024-2036 (USD Million)
Table 322. South Africa: Benchtop Sequencers Clinical Diagnostics & Oncology Market, by Type, 2024-2036 (USD Million)
Table 323. South Africa: Benchtop Sequencers Market, by End User, 2024-2036 (USD Million)
Table 324. Rest of Middle East & Africa: Benchtop Sequencers Market, by Product, 2024-2036 (USD Million)
Table 325. Rest of Middle East & Africa: Benchtop Sequencing Consumables & Reagents Market, by Type, 2024-2036 (USD Million)
Table 326. Rest of Middle East & Africa: Benchtop Sequencing Software & Services Market, by Type, 2024-2036 (USD Million)
Table 327. Rest of Middle East & Africa: Benchtop Sequencers Market, by Technology, 2024-2036 (USD Million)
Table 328. Rest of Middle East & Africa: Benchtop Sequencers Market, by Read Type, 2024-2036 (USD Million)
Table 329. Rest of Middle East & Africa: Benchtop Sequencers Market, by Throughput, 2024-2036 (USD Million)
Table 330. Rest of Middle East & Africa: Benchtop Sequencers Market, by Application, 2024-2036 (USD Million)
Table 331. Rest of Middle East & Africa: Benchtop Sequencers Clinical Diagnostics & Oncology Market, by Type, 2024-2036 (USD Million)
Table 332. Rest of Middle East & Africa: Benchtop Sequencers Market, by End User, 2024-2036 (USD Million)
Table 333. Benchtop Sequencers Market: Competitive Benchmarking, by Performance Metric
Table 334. Benchtop Sequencers Market: Competitive Benchmarking, by Technology and Portfolio Coverage
Table 33
Table 2. Indicative Benchtop Sequencer Capital Cost, by Platform Tier (2026)
Table 3. Comparative Assessment of Benchtop Sequencing Technologies (2026)
Table 4. Global Benchtop Sequencers Market, by Product, 2024-2036 (USD Million)
Table 5. Global Benchtop Sequencer Instruments Market, by Country/Region, 2024-2036 (USD Million)
Table 6. Global Benchtop Sequencing Consumables & Reagents Market, by Type, 2024-2036 (USD Million)
Table 7. Global Benchtop Sequencing Consumables & Reagents Market, by Country/Region, 2024-2036 (USD Million)
Table 8. Global Benchtop Sequencing Flow Cells & Chips Market, by Country/Region, 2024-2036 (USD Million)
Table 9. Global Benchtop Sequencing Reagents Market, by Country/Region, 2024-2036 (USD Million)
Table 10. Global Benchtop Sequencing Library Preparation Kits Market, by Country/Region, 2024-2036 (USD Million)
Table 11. Global Benchtop Sequencing Software & Services Market, by Type, 2024-2036 (USD Million)
Table 12. Global Benchtop Sequencing Software & Services Market, by Country/Region, 2024-2036 (USD Million)
Table 13. Global Benchtop Sequencing Bioinformatics & Analysis Software Market, by Country/Region, 2024-2036 (USD Million)
Table 14. Global Benchtop Sequencer Service & Support Market, by Country/Region, 2024-2036 (USD Million)
Table 15. Global Benchtop Sequencers Market, by Technology, 2024-2036 (USD Million)
Table 16. Global Benchtop Sequencers Market for Sequencing by Synthesis (SBS), by Country/Region, 2024-2036 (USD Million)
Table 17. Global Benchtop Sequencers Market for Ion Semiconductor Sequencing, by Country/Region, 2024-2036 (USD Million)
Table 18. Global Benchtop Sequencers Market for Nanopore Sequencing, by Country/Region, 2024-2036 (USD Million)
Table 19. Global Benchtop Sequencers Market for Avidity Sequencing, by Country/Region, 2024-2036 (USD Million)
Table 20. Global Benchtop Sequencers Market for Single-Molecule Real-Time (SMRT) Sequencing, by Country/Region, 2024-2036 (USD Million)
Table 21. Global Benchtop Sequencers Market for Other Technologies, by Country/Region, 2024-2036 (USD Million)
Table 22. Global Benchtop Sequencers Market, by Read Type, 2024-2036 (USD Million)
Table 23. Global Benchtop Sequencers Market for Short-read Sequencing, by Country/Region, 2024-2036 (USD Million)
Table 24. Global Benchtop Sequencers Market for Long-read Sequencing, by Country/Region, 2024-2036 (USD Million)
Table 25. Global Benchtop Sequencers Market, by Throughput, 2024-2036 (USD Million)
Table 26. Global Benchtop Sequencers Market for Low Throughput Sequencing, by Country/Region, 2024-2036 (USD Million)
Table 27. Global Benchtop Sequencers Market for Mid Throughput Sequencing, by Country/Region, 2024-2036 (USD Million)
Table 28. Global Benchtop Sequencers Market for High Throughput Sequencing, by Country/Region, 2024-2036 (USD Million)
Table 29. Global Benchtop Sequencers Market, by Application, 2024-2036 (USD Million)
Table 30. Global Benchtop Sequencers Market for Clinical Diagnostics & Oncology, by Type, 2024-2036 (USD Million)
Table 31. Global Benchtop Sequencers Market for Clinical Diagnostics & Oncology, by Country/Region, 2024-2036 (USD Million)
Table 32. Global Benchtop Sequencers Market for Comprehensive Genomic Profiling, by Country/Region, 2024-2036 (USD Million)
Table 33. Global Benchtop Sequencers Market for Minimal Residual Disease & Liquid Biopsy, by Country/Region, 2024-2036 (USD Million)
Table 34. Global Benchtop Sequencers Market for Hereditary & Rare Disease Testing, by Country/Region, 2024-2036 (USD Million)
Table 35. Global Benchtop Sequencers Market for Infectious Disease & Genomic Surveillance, by Country/Region, 2024-2036 (USD Million)
Table 36. Global Benchtop Sequencers Market for Reproductive & Genetic Health, by Country/Region, 2024-2036 (USD Million)
Table 37. Global Benchtop Sequencers Market for Drug Discovery & Translational Research, by Country/Region, 2024-2036 (USD Million)
Table 38. Global Benchtop Sequencers Market for Agrigenomics & Applied Testing, by Country/Region, 2024-2036 (USD Million)
Table 39. Global Benchtop Sequencers Market for Other Applications, by Country/Region, 2024-2036 (USD Million)
Table 40. Global Benchtop Sequencers Market, by End User, 2024-2036 (USD Million)
Table 41. Global Benchtop Sequencers Market for Hospitals & Clinical Laboratories, by Country/Region, 2024-2036 (USD Million)
Table 42. Global Benchtop Sequencers Market for Academic & Research Institutions, by Country/Region, 2024-2036 (USD Million)
Table 43. Global Benchtop Sequencers Market for Pharmaceutical & Biotechnology Companies, by Country/Region, 2024-2036 (USD Million)
Table 44. Global Benchtop Sequencers Market for Public Health & Government Laboratories, by Country/Region, 2024-2036 (USD Million)
Table 45. Global Benchtop Sequencers Market for CROs & Contract Testing Organizations, by Country/Region, 2024-2036 (USD Million)
Table 46. Global Benchtop Sequencers Market for Other End Users, by Country/Region, 2024-2036 (USD Million)
Table 47. Global Benchtop Sequencers Market, by Region, 2024-2036 (USD Million)
Table 48. Global Benchtop Sequencers Market, by Country/Region, 2024-2036 (USD Million)
Table 49. North America: Benchtop Sequencers Market, by Country/Region, 2024-2036 (USD Million)
Table 50. North America: Benchtop Sequencers Market, by Product, 2024-2036 (USD Million)
Table 51. North America: Benchtop Sequencing Consumables & Reagents Market, by Type, 2024-2036 (USD Million)
Table 52. North America: Benchtop Sequencing Software & Services Market, by Type, 2024-2036 (USD Million)
Table 53. North America: Benchtop Sequencers Market, by Technology, 2024-2036 (USD Million)
Table 54. North America: Benchtop Sequencers Market, by Read Type, 2024-2036 (USD Million)
Table 55. North America: Benchtop Sequencers Market, by Throughput, 2024-2036 (USD Million)
Table 56. North America: Benchtop Sequencers Market, by Application, 2024-2036 (USD Million)
Table 57. North America: Benchtop Sequencers Clinical Diagnostics & Oncology Market, by Type, 2024-2036 (USD Million)
Table 58. North America: Benchtop Sequencers Market, by End User, 2024-2036 (USD Million)
Table 59. U.S.: Benchtop Sequencers Market, by Product, 2024-2036 (USD Million)
Table 60. U.S.: Benchtop Sequencing Consumables & Reagents Market, by Type, 2024-2036 (USD Million)
Table 61. U.S.: Benchtop Sequencing Software & Services Market, by Type, 2024-2036 (USD Million)
Table 62. U.S.: Benchtop Sequencers Market, by Technology, 2024-2036 (USD Million)
Table 63. U.S.: Benchtop Sequencers Market, by Read Type, 2024-2036 (USD Million)
Table 64. U.S.: Benchtop Sequencers Market, by Throughput, 2024-2036 (USD Million)
Table 65. U.S.: Benchtop Sequencers Market, by Application, 2024-2036 (USD Million)
Table 66. U.S.: Benchtop Sequencers Clinical Diagnostics & Oncology Market, by Type, 2024-2036 (USD Million)
Table 67. U.S.: Benchtop Sequencers Market, by End User, 2024-2036 (USD Million)
Table 68. Canada: Benchtop Sequencers Market, by Product, 2024-2036 (USD Million)
Table 69. Canada: Benchtop Sequencing Consumables & Reagents Market, by Type, 2024-2036 (USD Million)
Table 70. Canada: Benchtop Sequencing Software & Services Market, by Type, 2024-2036 (USD Million)
Table 71. Canada: Benchtop Sequencers Market, by Technology, 2024-2036 (USD Million)
Table 72. Canada: Benchtop Sequencers Market, by Read Type, 2024-2036 (USD Million)
Table 73. Canada: Benchtop Sequencers Market, by Throughput, 2024-2036 (USD Million)
Table 74. Canada: Benchtop Sequencers Market, by Application, 2024-2036 (USD Million)
Table 75. Canada: Benchtop Sequencers Clinical Diagnostics & Oncology Market, by Type, 2024-2036 (USD Million)
Table 76. Canada: Benchtop Sequencers Market, by End User, 2024-2036 (USD Million)
Table 77. Europe: Benchtop Sequencers Market, by Country/Region, 2024-2036 (USD Million)
Table 78. Europe: Benchtop Sequencers Market, by Product, 2024-2036 (USD Million)
Table 79. Europe: Benchtop Sequencing Consumables & Reagents Market, by Type, 2024-2036 (USD Million)
Table 80. Europe: Benchtop Sequencing Software & Services Market, by Type, 2024-2036 (USD Million)
Table 81. Europe: Benchtop Sequencers Market, by Technology, 2024-2036 (USD Million)
Table 82. Europe: Benchtop Sequencers Market, by Read Type, 2024-2036 (USD Million)
Table 83. Europe: Benchtop Sequencers Market, by Throughput, 2024-2036 (USD Million)
Table 84. Europe: Benchtop Sequencers Market, by Application, 2024-2036 (USD Million)
Table 85. Europe: Benchtop Sequencers Clinical Diagnostics & Oncology Market, by Type, 2024-2036 (USD Million)
Table 86. Europe: Benchtop Sequencers Market, by End User, 2024-2036 (USD Million)
Table 87. Germany: Benchtop Sequencers Market, by Product, 2024-2036 (USD Million)
Table 88. Germany: Benchtop Sequencing Consumables & Reagents Market, by Type, 2024-2036 (USD Million)
Table 89. Germany: Benchtop Sequencing Software & Services Market, by Type, 2024-2036 (USD Million)
Table 90. Germany: Benchtop Sequencers Market, by Technology, 2024-2036 (USD Million)
Table 91. Germany: Benchtop Sequencers Market, by Read Type, 2024-2036 (USD Million)
Table 92. Germany: Benchtop Sequencers Market, by Throughput, 2024-2036 (USD Million)
Table 93. Germany: Benchtop Sequencers Market, by Application, 2024-2036 (USD Million)
Table 94. Germany: Benchtop Sequencers Clinical Diagnostics & Oncology Market, by Type, 2024-2036 (USD Million)
Table 95. Germany: Benchtop Sequencers Market, by End User, 2024-2036 (USD Million)
Table 96. U.K.: Benchtop Sequencers Market, by Product, 2024-2036 (USD Million)
Table 97. U.K.: Benchtop Sequencing Consumables & Reagents Market, by Type, 2024-2036 (USD Million)
Table 98. U.K.: Benchtop Sequencing Software & Services Market, by Type, 2024-2036 (USD Million)
Table 99. U.K.: Benchtop Sequencers Market, by Technology, 2024-2036 (USD Million)
Table 100. U.K.: Benchtop Sequencers Market, by Read Type, 2024-2036 (USD Million)
Table 101. U.K.: Benchtop Sequencers Market, by Throughput, 2024-2036 (USD Million)
Table 102. U.K.: Benchtop Sequencers Market, by Application, 2024-2036 (USD Million)
Table 103. U.K.: Benchtop Sequencers Clinical Diagnostics & Oncology Market, by Type, 2024-2036 (USD Million)
Table 104. U.K.: Benchtop Sequencers Market, by End User, 2024-2036 (USD Million)
Table 105. France: Benchtop Sequencers Market, by Product, 2024-2036 (USD Million)
Table 106. France: Benchtop Sequencing Consumables & Reagents Market, by Type, 2024-2036 (USD Million)
Table 107. France: Benchtop Sequencing Software & Services Market, by Type, 2024-2036 (USD Million)
Table 108. France: Benchtop Sequencers Market, by Technology, 2024-2036 (USD Million)
Table 109. France: Benchtop Sequencers Market, by Read Type, 2024-2036 (USD Million)
Table 110. France: Benchtop Sequencers Market, by Throughput, 2024-2036 (USD Million)
Table 111. France: Benchtop Sequencers Market, by Application, 2024-2036 (USD Million)
Table 112. France: Benchtop Sequencers Clinical Diagnostics & Oncology Market, by Type, 2024-2036 (USD Million)
Table 113. France: Benchtop Sequencers Market, by End User, 2024-2036 (USD Million)
Table 114. Italy: Benchtop Sequencers Market, by Product, 2024-2036 (USD Million)
Table 115. Italy: Benchtop Sequencing Consumables & Reagents Market, by Type, 2024-2036 (USD Million)
Table 116. Italy: Benchtop Sequencing Software & Services Market, by Type, 2024-2036 (USD Million)
Table 117. Italy: Benchtop Sequencers Market, by Technology, 2024-2036 (USD Million)
Table 118. Italy: Benchtop Sequencers Market, by Read Type, 2024-2036 (USD Million)
Table 119. Italy: Benchtop Sequencers Market, by Throughput, 2024-2036 (USD Million)
Table 120. Italy: Benchtop Sequencers Market, by Application, 2024-2036 (USD Million)
Table 121. Italy: Benchtop Sequencers Clinical Diagnostics & Oncology Market, by Type, 2024-2036 (USD Million)
Table 122. Italy: Benchtop Sequencers Market, by End User, 2024-2036 (USD Million)
Table 123. Spain: Benchtop Sequencers Market, by Product, 2024-2036 (USD Million)
Table 124. Spain: Benchtop Sequencing Consumables & Reagents Market, by Type, 2024-2036 (USD Million)
Table 125. Spain: Benchtop Sequencing Software & Services Market, by Type, 2024-2036 (USD Million)
Table 126. Spain: Benchtop Sequencers Market, by Technology, 2024-2036 (USD Million)
Table 127. Spain: Benchtop Sequencers Market, by Read Type, 2024-2036 (USD Million)
Table 128. Spain: Benchtop Sequencers Market, by Throughput, 2024-2036 (USD Million)
Table 129. Spain: Benchtop Sequencers Market, by Application, 2024-2036 (USD Million)
Table 130. Spain: Benchtop Sequencers Clinical Diagnostics & Oncology Market, by Type, 2024-2036 (USD Million)
Table 131. Spain: Benchtop Sequencers Market, by End User, 2024-2036 (USD Million)
Table 132. Switzerland: Benchtop Sequencers Market, by Product, 2024-2036 (USD Million)
Table 133. Switzerland: Benchtop Sequencing Consumables & Reagents Market, by Type, 2024-2036 (USD Million)
Table 134. Switzerland: Benchtop Sequencing Software & Services Market, by Type, 2024-2036 (USD Million)
Table 135. Switzerland: Benchtop Sequencers Market, by Technology, 2024-2036 (USD Million)
Table 136. Switzerland: Benchtop Sequencers Market, by Read Type, 2024-2036 (USD Million)
Table 137. Switzerland: Benchtop Sequencers Market, by Throughput, 2024-2036 (USD Million)
Table 138. Switzerland: Benchtop Sequencers Market, by Application, 2024-2036 (USD Million)
Table 139. Switzerland: Benchtop Sequencers Clinical Diagnostics & Oncology Market, by Type, 2024-2036 (USD Million)
Table 140. Switzerland: Benchtop Sequencers Market, by End User, 2024-2036 (USD Million)
Table 141. Netherlands: Benchtop Sequencers Market, by Product, 2024-2036 (USD Million)
Table 142. Netherlands: Benchtop Sequencing Consumables & Reagents Market, by Type, 2024-2036 (USD Million)
Table 143. Netherlands: Benchtop Sequencing Software & Services Market, by Type, 2024-2036 (USD Million)
Table 144. Netherlands: Benchtop Sequencers Market, by Technology, 2024-2036 (USD Million)
Table 145. Netherlands: Benchtop Sequencers Market, by Read Type, 2024-2036 (USD Million)
Table 146. Netherlands: Benchtop Sequencers Market, by Throughput, 2024-2036 (USD Million)
Table 147. Netherlands: Benchtop Sequencers Market, by Application, 2024-2036 (USD Million)
Table 148. Netherlands: Benchtop Sequencers Clinical Diagnostics & Oncology Market, by Type, 2024-2036 (USD Million)
Table 149. Netherlands: Benchtop Sequencers Market, by End User, 2024-2036 (USD Million)
Table 150. Nordic Countries: Benchtop Sequencers Market, by Product, 2024-2036 (USD Million)
Table 151. Nordic Countries: Benchtop Sequencing Consumables & Reagents Market, by Type, 2024-2036 (USD Million)
Table 152. Nordic Countries: Benchtop Sequencing Software & Services Market, by Type, 2024-2036 (USD Million)
Table 153. Nordic Countries: Benchtop Sequencers Market, by Technology, 2024-2036 (USD Million)
Table 154. Nordic Countries: Benchtop Sequencers Market, by Read Type, 2024-2036 (USD Million)
Table 155. Nordic Countries: Benchtop Sequencers Market, by Throughput, 2024-2036 (USD Million)
Table 156. Nordic Countries: Benchtop Sequencers Market, by Application, 2024-2036 (USD Million)
Table 157. Nordic Countries: Benchtop Sequencers Clinical Diagnostics & Oncology Market, by Type, 2024-2036 (USD Million)
Table 158. Nordic Countries: Benchtop Sequencers Market, by End User, 2024-2036 (USD Million)
Table 159. Rest of Europe: Benchtop Sequencers Market, by Product, 2024-2036 (USD Million)
Table 160. Rest of Europe: Benchtop Sequencing Consumables & Reagents Market, by Type, 2024-2036 (USD Million)
Table 161. Rest of Europe: Benchtop Sequencing Software & Services Market, by Type, 2024-2036 (USD Million)
Table 162. Rest of Europe: Benchtop Sequencers Market, by Technology, 2024-2036 (USD Million)
Table 163. Rest of Europe: Benchtop Sequencers Market, by Read Type, 2024-2036 (USD Million)
Table 164. Rest of Europe: Benchtop Sequencers Market, by Throughput, 2024-2036 (USD Million)
Table 165. Rest of Europe: Benchtop Sequencers Market, by Application, 2024-2036 (USD Million)
Table 166. Rest of Europe: Benchtop Sequencers Clinical Diagnostics & Oncology Market, by Type, 2024-2036 (USD Million)
Table 167. Rest of Europe: Benchtop Sequencers Market, by End User, 2024-2036 (USD Million)
Table 168. Asia-Pacific: Benchtop Sequencers Market, by Country/Region, 2024-2036 (USD Million)
Table 169. Asia-Pacific: Benchtop Sequencers Market, by Product, 2024-2036 (USD Million)
Table 170. Asia-Pacific: Benchtop Sequencing Consumables & Reagents Market, by Type, 2024-2036 (USD Million)
Table 171. Asia-Pacific: Benchtop Sequencing Software & Services Market, by Type, 2024-2036 (USD Million)
Table 172. Asia-Pacific: Benchtop Sequencers Market, by Technology, 2024-2036 (USD Million)
Table 173. Asia-Pacific: Benchtop Sequencers Market, by Read Type, 2024-2036 (USD Million)
Table 174. Asia-Pacific: Benchtop Sequencers Market, by Throughput, 2024-2036 (USD Million)
Table 175. Asia-Pacific: Benchtop Sequencers Market, by Application, 2024-2036 (USD Million)
Table 176. Asia-Pacific: Benchtop Sequencers Clinical Diagnostics & Oncology Market, by Type, 2024-2036 (USD Million)
Table 177. Asia-Pacific: Benchtop Sequencers Market, by End User, 2024-2036 (USD Million)
Table 178. China: Benchtop Sequencers Market, by Product, 2024-2036 (USD Million)
Table 179. China: Benchtop Sequencing Consumables & Reagents Market, by Type, 2024-2036 (USD Million)
Table 180. China: Benchtop Sequencing Software & Services Market, by Type, 2024-2036 (USD Million)
Table 181. China: Benchtop Sequencers Market, by Technology, 2024-2036 (USD Million)
Table 182. China: Benchtop Sequencers Market, by Read Type, 2024-2036 (USD Million)
Table 183. China: Benchtop Sequencers Market, by Throughput, 2024-2036 (USD Million)
Table 184. China: Benchtop Sequencers Market, by Application, 2024-2036 (USD Million)
Table 185. China: Benchtop Sequencers Clinical Diagnostics & Oncology Market, by Type, 2024-2036 (USD Million)
Table 186. China: Benchtop Sequencers Market, by End User, 2024-2036 (USD Million)
Table 187. Japan: Benchtop Sequencers Market, by Product, 2024-2036 (USD Million)
Table 188. Japan: Benchtop Sequencing Consumables & Reagents Market, by Type, 2024-2036 (USD Million)
Table 189. Japan: Benchtop Sequencing Software & Services Market, by Type, 2024-2036 (USD Million)
Table 190. Japan: Benchtop Sequencers Market, by Technology, 2024-2036 (USD Million)
Table 191. Japan: Benchtop Sequencers Market, by Read Type, 2024-2036 (USD Million)
Table 192. Japan: Benchtop Sequencers Market, by Throughput, 2024-2036 (USD Million)
Table 193. Japan: Benchtop Sequencers Market, by Application, 2024-2036 (USD Million)
Table 194. Japan: Benchtop Sequencers Clinical Diagnostics & Oncology Market, by Type, 2024-2036 (USD Million)
Table 195. Japan: Benchtop Sequencers Market, by End User, 2024-2036 (USD Million)
Table 196. India: Benchtop Sequencers Market, by Product, 2024-2036 (USD Million)
Table 197. India: Benchtop Sequencing Consumables & Reagents Market, by Type, 2024-2036 (USD Million)
Table 198. India: Benchtop Sequencing Software & Services Market, by Type, 2024-2036 (USD Million)
Table 199. India: Benchtop Sequencers Market, by Technology, 2024-2036 (USD Million)
Table 200. India: Benchtop Sequencers Market, by Read Type, 2024-2036 (USD Million)
Table 201. India: Benchtop Sequencers Market, by Throughput, 2024-2036 (USD Million)
Table 202. India: Benchtop Sequencers Market, by Application, 2024-2036 (USD Million)
Table 203. India: Benchtop Sequencers Clinical Diagnostics & Oncology Market, by Type, 2024-2036 (USD Million)
Table 204. India: Benchtop Sequencers Market, by End User, 2024-2036 (USD Million)
Table 205. South Korea: Benchtop Sequencers Market, by Product, 2024-2036 (USD Million)
Table 206. South Korea: Benchtop Sequencing Consumables & Reagents Market, by Type, 2024-2036 (USD Million)
Table 207. South Korea: Benchtop Sequencing Software & Services Market, by Type, 2024-2036 (USD Million)
Table 208. South Korea: Benchtop Sequencers Market, by Technology, 2024-2036 (USD Million)
Table 209. South Korea: Benchtop Sequencers Market, by Read Type, 2024-2036 (USD Million)
Table 210. South Korea: Benchtop Sequencers Market, by Throughput, 2024-2036 (USD Million)
Table 211. South Korea: Benchtop Sequencers Market, by Application, 2024-2036 (USD Million)
Table 212. South Korea: Benchtop Sequencers Clinical Diagnostics & Oncology Market, by Type, 2024-2036 (USD Million)
Table 213. South Korea: Benchtop Sequencers Market, by End User, 2024-2036 (USD Million)
Table 214. Singapore: Benchtop Sequencers Market, by Product, 2024-2036 (USD Million)
Table 215. Singapore: Benchtop Sequencing Consumables & Reagents Market, by Type, 2024-2036 (USD Million)
Table 216. Singapore: Benchtop Sequencing Software & Services Market, by Type, 2024-2036 (USD Million)
Table 217. Singapore: Benchtop Sequencers Market, by Technology, 2024-2036 (USD Million)
Table 218. Singapore: Benchtop Sequencers Market, by Read Type, 2024-2036 (USD Million)
Table 219. Singapore: Benchtop Sequencers Market, by Throughput, 2024-2036 (USD Million)
Table 220. Singapore: Benchtop Sequencers Market, by Application, 2024-2036 (USD Million)
Table 221. Singapore: Benchtop Sequencers Clinical Diagnostics & Oncology Market, by Type, 2024-2036 (USD Million)
Table 222. Singapore: Benchtop Sequencers Market, by End User, 2024-2036 (USD Million)
Table 223. Australia & New Zealand: Benchtop Sequencers Market, by Product, 2024-2036 (USD Million)
Table 224. Australia & New Zealand: Benchtop Sequencing Consumables & Reagents Market, by Type, 2024-2036 (USD Million)
Table 225. Australia & New Zealand: Benchtop Sequencing Software & Services Market, by Type, 2024-2036 (USD Million)
Table 226. Australia & New Zealand: Benchtop Sequencers Market, by Technology, 2024-2036 (USD Million)
Table 227. Australia & New Zealand: Benchtop Sequencers Market, by Read Type, 2024-2036 (USD Million)
Table 228. Australia & New Zealand: Benchtop Sequencers Market, by Throughput, 2024-2036 (USD Million)
Table 229. Australia & New Zealand: Benchtop Sequencers Market, by Application, 2024-2036 (USD Million)
Table 230. Australia & New Zealand: Benchtop Sequencers Clinical Diagnostics & Oncology Market, by Type, 2024-2036 (USD Million)
Table 231. Australia & New Zealand: Benchtop Sequencers Market, by End User, 2024-2036 (USD Million)
Table 232. Rest of Asia-Pacific: Benchtop Sequencers Market, by Product, 2024-2036 (USD Million)
Table 233. Rest of Asia-Pacific: Benchtop Sequencing Consumables & Reagents Market, by Type, 2024-2036 (USD Million)
Table 234. Rest of Asia-Pacific: Benchtop Sequencing Software & Services Market, by Type, 2024-2036 (USD Million)
Table 235. Rest of Asia-Pacific: Benchtop Sequencers Market, by Technology, 2024-2036 (USD Million)
Table 236. Rest of Asia-Pacific: Benchtop Sequencers Market, by Read Type, 2024-2036 (USD Million)
Table 237. Rest of Asia-Pacific: Benchtop Sequencers Market, by Throughput, 2024-2036 (USD Million)
Table 238. Rest of Asia-Pacific: Benchtop Sequencers Market, by Application, 2024-2036 (USD Million)
Table 239. Rest of Asia-Pacific: Benchtop Sequencers Clinical Diagnostics & Oncology Market, by Type, 2024-2036 (USD Million)
Table 240. Rest of Asia-Pacific: Benchtop Sequencers Market, by End User, 2024-2036 (USD Million)
Table 241. Latin America: Benchtop Sequencers Market, by Country/Region, 2024-2036 (USD Million)
Table 242. Latin America: Benchtop Sequencers Market, by Product, 2024-2036 (USD Million)
Table 243. Latin America: Benchtop Sequencing Consumables & Reagents Market, by Type, 2024-2036 (USD Million)
Table 244. Latin America: Benchtop Sequencing Software & Services Market, by Type, 2024-2036 (USD Million)
Table 245. Latin America: Benchtop Sequencers Market, by Technology, 2024-2036 (USD Million)
Table 246. Latin America: Benchtop Sequencers Market, by Read Type, 2024-2036 (USD Million)
Table 247. Latin America: Benchtop Sequencers Market, by Throughput, 2024-2036 (USD Million)
Table 248. Latin America: Benchtop Sequencers Market, by Application, 2024-2036 (USD Million)
Table 249. Latin America: Benchtop Sequencers Clinical Diagnostics & Oncology Market, by Type, 2024-2036 (USD Million)
Table 250. Latin America: Benchtop Sequencers Market, by End User, 2024-2036 (USD Million)
Table 251. Brazil: Benchtop Sequencers Market, by Product, 2024-2036 (USD Million)
Table 252. Brazil: Benchtop Sequencing Consumables & Reagents Market, by Type, 2024-2036 (USD Million)
Table 253. Brazil: Benchtop Sequencing Software & Services Market, by Type, 2024-2036 (USD Million)
Table 254. Brazil: Benchtop Sequencers Market, by Technology, 2024-2036 (USD Million)
Table 255. Brazil: Benchtop Sequencers Market, by Read Type, 2024-2036 (USD Million)
Table 256. Brazil: Benchtop Sequencers Market, by Throughput, 2024-2036 (USD Million)
Table 257. Brazil: Benchtop Sequencers Market, by Application, 2024-2036 (USD Million)
Table 258. Brazil: Benchtop Sequencers Clinical Diagnostics & Oncology Market, by Type, 2024-2036 (USD Million)
Table 259. Brazil: Benchtop Sequencers Market, by End User, 2024-2036 (USD Million)
Table 260. Mexico: Benchtop Sequencers Market, by Product, 2024-2036 (USD Million)
Table 261. Mexico: Benchtop Sequencing Consumables & Reagents Market, by Type, 2024-2036 (USD Million)
Table 262. Mexico: Benchtop Sequencing Software & Services Market, by Type, 2024-2036 (USD Million)
Table 263. Mexico: Benchtop Sequencers Market, by Technology, 2024-2036 (USD Million)
Table 264. Mexico: Benchtop Sequencers Market, by Read Type, 2024-2036 (USD Million)
Table 265. Mexico: Benchtop Sequencers Market, by Throughput, 2024-2036 (USD Million)
Table 266. Mexico: Benchtop Sequencers Market, by Application, 2024-2036 (USD Million)
Table 267. Mexico: Benchtop Sequencers Clinical Diagnostics & Oncology Market, by Type, 2024-2036 (USD Million)
Table 268. Mexico: Benchtop Sequencers Market, by End User, 2024-2036 (USD Million)
Table 269. Rest of Latin America: Benchtop Sequencers Market, by Product, 2024-2036 (USD Million)
Table 270. Rest of Latin America: Benchtop Sequencing Consumables & Reagents Market, by Type, 2024-2036 (USD Million)
Table 271. Rest of Latin America: Benchtop Sequencing Software & Services Market, by Type, 2024-2036 (USD Million)
Table 272. Rest of Latin America: Benchtop Sequencers Market, by Technology, 2024-2036 (USD Million)
Table 273. Rest of Latin America: Benchtop Sequencers Market, by Read Type, 2024-2036 (USD Million)
Table 274. Rest of Latin America: Benchtop Sequencers Market, by Throughput, 2024-2036 (USD Million)
Table 275. Rest of Latin America: Benchtop Sequencers Market, by Application, 2024-2036 (USD Million)
Table 276. Rest of Latin America: Benchtop Sequencers Clinical Diagnostics & Oncology Market, by Type, 2024-2036 (USD Million)
Table 277. Rest of Latin America: Benchtop Sequencers Market, by End User, 2024-2036 (USD Million)
Table 278. Middle East & Africa: Benchtop Sequencers Market, by Country/Region, 2024-2036 (USD Million)
Table 279. Middle East & Africa: Benchtop Sequencers Market, by Product, 2024-2036 (USD Million)
Table 280. Middle East & Africa: Benchtop Sequencing Consumables & Reagents Market, by Type, 2024-2036 (USD Million)
Table 281. Middle East & Africa: Benchtop Sequencing Software & Services Market, by Type, 2024-2036 (USD Million)
Table 282. Middle East & Africa: Benchtop Sequencers Market, by Technology, 2024-2036 (USD Million)
Table 283. Middle East & Africa: Benchtop Sequencers Market, by Read Type, 2024-2036 (USD Million)
Table 284. Middle East & Africa: Benchtop Sequencers Market, by Throughput, 2024-2036 (USD Million)
Table 285. Middle East & Africa: Benchtop Sequencers Market, by Application, 2024-2036 (USD Million)
Table 286. Middle East & Africa: Benchtop Sequencers Clinical Diagnostics & Oncology Market, by Type, 2024-2036 (USD Million)
Table 287. Middle East & Africa: Benchtop Sequencers Market, by End User, 2024-2036 (USD Million)
Table 288. Saudi Arabia: Benchtop Sequencers Market, by Product, 2024-2036 (USD Million)
Table 289. Saudi Arabia: Benchtop Sequencing Consumables & Reagents Market, by Type, 2024-2036 (USD Million)
Table 290. Saudi Arabia: Benchtop Sequencing Software & Services Market, by Type, 2024-2036 (USD Million)
Table 291. Saudi Arabia: Benchtop Sequencers Market, by Technology, 2024-2036 (USD Million)
Table 292. Saudi Arabia: Benchtop Sequencers Market, by Read Type, 2024-2036 (USD Million)
Table 293. Saudi Arabia: Benchtop Sequencers Market, by Throughput, 2024-2036 (USD Million)
Table 294. Saudi Arabia: Benchtop Sequencers Market, by Application, 2024-2036 (USD Million)
Table 295. Saudi Arabia: Benchtop Sequencers Clinical Diagnostics & Oncology Market, by Type, 2024-2036 (USD Million)
Table 296. Saudi Arabia: Benchtop Sequencers Market, by End User, 2024-2036 (USD Million)
Table 297. U.A.E.: Benchtop Sequencers Market, by Product, 2024-2036 (USD Million)
Table 298. U.A.E.: Benchtop Sequencing Consumables & Reagents Market, by Type, 2024-2036 (USD Million)
Table 299. U.A.E.: Benchtop Sequencing Software & Services Market, by Type, 2024-2036 (USD Million)
Table 300. U.A.E.: Benchtop Sequencers Market, by Technology, 2024-2036 (USD Million)
Table 301. U.A.E.: Benchtop Sequencers Market, by Read Type, 2024-2036 (USD Million)
Table 302. U.A.E.: Benchtop Sequencers Market, by Throughput, 2024-2036 (USD Million)
Table 303. U.A.E.: Benchtop Sequencers Market, by Application, 2024-2036 (USD Million)
Table 304. U.A.E.: Benchtop Sequencers Clinical Diagnostics & Oncology Market, by Type, 2024-2036 (USD Million)
Table 305. U.A.E.: Benchtop Sequencers Market, by End User, 2024-2036 (USD Million)
Table 306. Israel: Benchtop Sequencers Market, by Product, 2024-2036 (USD Million)
Table 307. Israel: Benchtop Sequencing Consumables & Reagents Market, by Type, 2024-2036 (USD Million)
Table 308. Israel: Benchtop Sequencing Software & Services Market, by Type, 2024-2036 (USD Million)
Table 309. Israel: Benchtop Sequencers Market, by Technology, 2024-2036 (USD Million)
Table 310. Israel: Benchtop Sequencers Market, by Read Type, 2024-2036 (USD Million)
Table 311. Israel: Benchtop Sequencers Market, by Throughput, 2024-2036 (USD Million)
Table 312. Israel: Benchtop Sequencers Market, by Application, 2024-2036 (USD Million)
Table 313. Israel: Benchtop Sequencers Clinical Diagnostics & Oncology Market, by Type, 2024-2036 (USD Million)
Table 314. Israel: Benchtop Sequencers Market, by End User, 2024-2036 (USD Million)
Table 315. South Africa: Benchtop Sequencers Market, by Product, 2024-2036 (USD Million)
Table 316. South Africa: Benchtop Sequencing Consumables & Reagents Market, by Type, 2024-2036 (USD Million)
Table 317. South Africa: Benchtop Sequencing Software & Services Market, by Type, 2024-2036 (USD Million)
Table 318. South Africa: Benchtop Sequencers Market, by Technology, 2024-2036 (USD Million)
Table 319. South Africa: Benchtop Sequencers Market, by Read Type, 2024-2036 (USD Million)
Table 320. South Africa: Benchtop Sequencers Market, by Throughput, 2024-2036 (USD Million)
Table 321. South Africa: Benchtop Sequencers Market, by Application, 2024-2036 (USD Million)
Table 322. South Africa: Benchtop Sequencers Clinical Diagnostics & Oncology Market, by Type, 2024-2036 (USD Million)
Table 323. South Africa: Benchtop Sequencers Market, by End User, 2024-2036 (USD Million)
Table 324. Rest of Middle East & Africa: Benchtop Sequencers Market, by Product, 2024-2036 (USD Million)
Table 325. Rest of Middle East & Africa: Benchtop Sequencing Consumables & Reagents Market, by Type, 2024-2036 (USD Million)
Table 326. Rest of Middle East & Africa: Benchtop Sequencing Software & Services Market, by Type, 2024-2036 (USD Million)
Table 327. Rest of Middle East & Africa: Benchtop Sequencers Market, by Technology, 2024-2036 (USD Million)
Table 328. Rest of Middle East & Africa: Benchtop Sequencers Market, by Read Type, 2024-2036 (USD Million)
Table 329. Rest of Middle East & Africa: Benchtop Sequencers Market, by Throughput, 2024-2036 (USD Million)
Table 330. Rest of Middle East & Africa: Benchtop Sequencers Market, by Application, 2024-2036 (USD Million)
Table 331. Rest of Middle East & Africa: Benchtop Sequencers Clinical Diagnostics & Oncology Market, by Type, 2024-2036 (USD Million)
Table 332. Rest of Middle East & Africa: Benchtop Sequencers Market, by End User, 2024-2036 (USD Million)
Table 333. Benchtop Sequencers Market: Competitive Benchmarking, by Performance Metric
Table 334. Benchtop Sequencers Market: Competitive Benchmarking, by Technology and Portfolio Coverage
Table 33
List of Figures
Figure 1. Benchtop Sequencers Market Ecosystem
Figure 2. Key Stakeholders in the Benchtop Sequencers Market
Figure 3. Research Process
Figure 4. Secondary Sources Referenced for This Study
Figure 5. Primary Research Techniques
Figure 6. Key Executives Interviewed
Figure 7. Breakdown of Primary Interviews (Supply-Side & Demand-Side)
Figure 8. Market Sizing and Growth Forecast Approach
Figure 9. Data Triangulation
Figure 10. Global Benchtop Sequencers Market, by Product, 2026 vs. 2036 (USD Million)
Figure 11. Global Benchtop Sequencers Market, by Technology, 2026 vs. 2036 (USD Million)
Figure 12. Global Benchtop Sequencers Market, by Application, 2026 vs. 2036 (USD Million)
Figure 13. Global Benchtop Sequencers Market, by Geography, 2026 vs. 2036 (USD Million)
Figure 14. Impact Analysis of Market Dynamics
Figure 15. Vendor Selection Criteria in Benchtop Sequencer Purchases
Figure 16. Representative Use Cases for Benchtop Sequencers
Figure 17. Porter's Five Forces Analysis
Figure 18. Value Chain of the Benchtop Sequencers Market
Figure 19. Benchtop Sequencing Technology Landscape
Figure 20. Regulatory Framework for Benchtop Sequencing
Figure 21. PESTEL Analysis of the Benchtop Sequencers Market
Figure 22. Global Benchtop Sequencers Market, by Product, 2026 Share and CAGR (2026-2036)
Figure 23. Global Benchtop Sequencers Market, by Technology, 2026 Share and CAGR (2026-2036)
Figure 24. Global Benchtop Sequencers Market, by Read Type, 2026 Share and CAGR (2026-2036)
Figure 25. Global Benchtop Sequencers Market, by Throughput, 2026 Share and CAGR (2026-2036)
Figure 26. Global Benchtop Sequencers Market, by Application, 2026 Share and CAGR (2026-2036)
Figure 27. Global Benchtop Sequencers Market, by End User, 2026 Share and CAGR (2026-2036)
Figure 28. Global Benchtop Sequencers Market, by Region, 2026 Share and CAGR (2026-2036)
Figure 29. Global Benchtop Sequencers Market: Top 15 Countries, 2026 vs. 2036 (USD Million)
Figure 30. North America: Benchtop Sequencers Market Snapshot, 2026 vs. 2036 (USD Million)
Figure 31. Europe: Benchtop Sequencers Market Snapshot, 2026 vs. 2036 (USD Million)
Figure 32. Asia-Pacific: Benchtop Sequencers Market Snapshot, 2026 vs. 2036 (USD Million)
Figure 33. Latin America: Benchtop Sequencers Market Snapshot, 2026 vs. 2036 (USD Million)
Figure 34. Middle East & Africa: Benchtop Sequencers Market Snapshot, 2026 vs. 2036 (USD Million)
Figure 35. Key Growth Strategies Adopted by Leading Players (2023-2026)
Figure 36. Competitive Dashboard: Benchtop Sequencers Market
Figure 37. Benchtop Sequencers Market: Market Share Analysis, by Key Player (2025)
Figure 38. Illumina, Inc.: Financial Snapshot (2025)
Figure 39. Illumina, Inc.: SWOT Analysis
Figure 40. Thermo Fisher Scientific Inc.: Financial Snapshot (2025)
Figure 41. Thermo Fisher Scientific Inc.: SWOT Analysis
Figure 42. Oxford Nanopore Technologies plc: Financial Snapshot (2025)
Figure 43. Oxford Nanopore Technologies plc: SWOT Analysis
Figure 44. Pacific Biosciences of California, Inc.: Financial Snapshot (2025)
Figure 45. Pacific Biosciences of California, Inc.: SWOT Analysis
Figure 46. Element Biosciences, Inc.: Financial Snapshot (2025)
Figure 47. Element Biosciences, Inc.: SWOT Analysis
Figure 48. MGI Tech Co., Ltd.: Financial Snapshot (2024)
Figure 49. MGI Tech Co., Ltd.: SWOT Analysis
Figure 50. Complete Genomics, Inc.: SWOT Analysis
Figure 51. Singular Genomics Systems, Inc.: SWOT Analysis
Figure 52. GeneMind Biosciences Co., Ltd.: SWOT Analysis
Figure 53. Salus BioMed: SWOT Analysis
Figure 54. Qitan Technology Co., Ltd.: SWOT Analysis
Figure 2. Key Stakeholders in the Benchtop Sequencers Market
Figure 3. Research Process
Figure 4. Secondary Sources Referenced for This Study
Figure 5. Primary Research Techniques
Figure 6. Key Executives Interviewed
Figure 7. Breakdown of Primary Interviews (Supply-Side & Demand-Side)
Figure 8. Market Sizing and Growth Forecast Approach
Figure 9. Data Triangulation
Figure 10. Global Benchtop Sequencers Market, by Product, 2026 vs. 2036 (USD Million)
Figure 11. Global Benchtop Sequencers Market, by Technology, 2026 vs. 2036 (USD Million)
Figure 12. Global Benchtop Sequencers Market, by Application, 2026 vs. 2036 (USD Million)
Figure 13. Global Benchtop Sequencers Market, by Geography, 2026 vs. 2036 (USD Million)
Figure 14. Impact Analysis of Market Dynamics
Figure 15. Vendor Selection Criteria in Benchtop Sequencer Purchases
Figure 16. Representative Use Cases for Benchtop Sequencers
Figure 17. Porter's Five Forces Analysis
Figure 18. Value Chain of the Benchtop Sequencers Market
Figure 19. Benchtop Sequencing Technology Landscape
Figure 20. Regulatory Framework for Benchtop Sequencing
Figure 21. PESTEL Analysis of the Benchtop Sequencers Market
Figure 22. Global Benchtop Sequencers Market, by Product, 2026 Share and CAGR (2026-2036)
Figure 23. Global Benchtop Sequencers Market, by Technology, 2026 Share and CAGR (2026-2036)
Figure 24. Global Benchtop Sequencers Market, by Read Type, 2026 Share and CAGR (2026-2036)
Figure 25. Global Benchtop Sequencers Market, by Throughput, 2026 Share and CAGR (2026-2036)
Figure 26. Global Benchtop Sequencers Market, by Application, 2026 Share and CAGR (2026-2036)
Figure 27. Global Benchtop Sequencers Market, by End User, 2026 Share and CAGR (2026-2036)
Figure 28. Global Benchtop Sequencers Market, by Region, 2026 Share and CAGR (2026-2036)
Figure 29. Global Benchtop Sequencers Market: Top 15 Countries, 2026 vs. 2036 (USD Million)
Figure 30. North America: Benchtop Sequencers Market Snapshot, 2026 vs. 2036 (USD Million)
Figure 31. Europe: Benchtop Sequencers Market Snapshot, 2026 vs. 2036 (USD Million)
Figure 32. Asia-Pacific: Benchtop Sequencers Market Snapshot, 2026 vs. 2036 (USD Million)
Figure 33. Latin America: Benchtop Sequencers Market Snapshot, 2026 vs. 2036 (USD Million)
Figure 34. Middle East & Africa: Benchtop Sequencers Market Snapshot, 2026 vs. 2036 (USD Million)
Figure 35. Key Growth Strategies Adopted by Leading Players (2023-2026)
Figure 36. Competitive Dashboard: Benchtop Sequencers Market
Figure 37. Benchtop Sequencers Market: Market Share Analysis, by Key Player (2025)
Figure 38. Illumina, Inc.: Financial Snapshot (2025)
Figure 39. Illumina, Inc.: SWOT Analysis
Figure 40. Thermo Fisher Scientific Inc.: Financial Snapshot (2025)
Figure 41. Thermo Fisher Scientific Inc.: SWOT Analysis
Figure 42. Oxford Nanopore Technologies plc: Financial Snapshot (2025)
Figure 43. Oxford Nanopore Technologies plc: SWOT Analysis
Figure 44. Pacific Biosciences of California, Inc.: Financial Snapshot (2025)
Figure 45. Pacific Biosciences of California, Inc.: SWOT Analysis
Figure 46. Element Biosciences, Inc.: Financial Snapshot (2025)
Figure 47. Element Biosciences, Inc.: SWOT Analysis
Figure 48. MGI Tech Co., Ltd.: Financial Snapshot (2024)
Figure 49. MGI Tech Co., Ltd.: SWOT Analysis
Figure 50. Complete Genomics, Inc.: SWOT Analysis
Figure 51. Singular Genomics Systems, Inc.: SWOT Analysis
Figure 52. GeneMind Biosciences Co., Ltd.: SWOT Analysis
Figure 53. Salus BioMed: SWOT Analysis
Figure 54. Qitan Technology Co., Ltd.: SWOT Analysis
Companies Mentioned
- Illumina, Inc.
- Thermo Fisher Scientific Inc.
- F. Hoffmann-La Roche Ltd
- Oxford Nanopore Technologies plc
- Pacific Biosciences of California, Inc.
- Element Biosciences, Inc.
- MGI Tech Co., Ltd.
- QIAGEN N.V.
- Agilent Technologies, Inc.
- BGI Genomics Co., Ltd.
- Singular Genomics Systems, Inc.
- Ultima Genomics, Inc.
- Twist Bioscience Corporation
- 10x Genomics, Inc.
- Bio-Rad Laboratories, Inc. (U.S.).
